<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management and prevention of pain in neonates</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management and prevention of pain in neonates</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management and prevention of pain in neonates</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jean-Michel Roué, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard Martin, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 10, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Neonates, especially those cared for in the neonatal intensive care unit (NICU) setting, frequently experience painful procedures. Pain assessment and management is a routine part of neonatal care. </p><p>The management and prevention of pain in neonates will be reviewed here. Assessment of pain in neonates is discussed separately. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates"</a>.)</p><p class="headingAnchor" id="H3521409746"><span class="h1">MISCONCEPTIONS ABOUT NEONATAL PAIN</span><span class="headingEndMark"> — </span>Historically, treatment and prevention of pain in neonates have been underemphasized because of the following <strong>misconceptions</strong>:</p><p class="bulletIndent1"><span class="glyph">●</span>Neural pathways in neonates are unmyelinated or otherwise immature and cannot transmit painful stimuli to the brain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is no alternative for verbal self-report, which remains the "gold standard" for conveying a subjective experience like pain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pain perception is located only in the cortex, and thalamocortical connections must be fully developed in order to allow pain perception.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The human infant does not have the psychological context necessary to identify experiences as painful; this ability does not develop until the age of two years or later.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Analgesic or sedative drugs cannot be used in neonates because the risk of adverse effects is too high.</p><p></p><p>These misconceptions are not supported by scientific evidence. Instead, there is increasing evidence that neonates experience pain and stress, as discussed separately. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Neonatal responses to pain'</a>.)</p><p class="headingAnchor" id="H1560057182"><span class="h1">GOALS OF PAIN MANAGEMENT</span><span class="headingEndMark"> — </span>Accumulating evidence suggests that repeated exposure to pain during the neonatal period, especially when undertreated, may have long-term adverse effects. These data are discussed separately. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Long-term effects of neonatal pain'</a>.) </p><p>Management and prevention of pain in this vulnerable population is therefore a fundamental part of neonatal practice [<a href="#rid1">1</a>].</p><p>The goals of an effective pain management program are to:</p><p class="bulletIndent1"><span class="glyph">●</span>Anticipate and recognize pain in neonates (eg, using validated pain assessment tools  (<a class="graphic graphic_table graphicRef80078" href="/d/graphic/80078.html" rel="external">table 1</a>)). (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Pain assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eliminate or minimize the neonate's exposure to unnecessary painful or stressful procedures and limit the duration of interventions that cause prolonged or continuous pain and stress.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When painful procedures or interventions are necessary, ensure adequate analgesia while minimizing adverse side effects. Achieving an optimal balance between these two aims can be challenging and requires a team-based approach.</p><p></p><p>Healthcare facilities caring for neonates and young infants should establish standardized practices for pain assessment and management to ensure that neonates receive adequate pain control [<a href="#rid1">1-3</a>].</p><p class="headingAnchor" id="H4262465332"><span class="h1">MULTIMODAL APPROACH</span><span class="headingEndMark"> — </span>A multimodal approach to neonatal pain management includes: </p><p class="bulletIndent1"><span class="glyph">●</span>Nonpharmacologic measures (eg, skin-to-skin contact, breastfeeding, non-nutritive sucking, swaddling) (see <a class="local">'Nonpharmacologic measures'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Topical or local anesthetics (see <a class="local">'Topical anesthetics'</a> below and <a class="local">'Local anesthesia'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic analgesic medications (see <a class="local">'Acetaminophen'</a> below and <a class="local">'Opioids'</a> below)</p><p></p><p>In some cases, nonpharmacologic measures alone may be sufficient. The need for specific analgesic drug therapy depends on the degree of anticipated procedural pain (when managing pain proactively) and/or the severity of pain demonstrated by the neonate (when managing pain reactively). </p><p>Multimodal approaches are generally more effective than a single intervention alone [<a href="#rid4">4-7</a>]. Combinations of nonpharmacologic measures (eg, skin-to-skin contact plus non-nutritive sucking) have additive or synergistic effects [<a href="#rid5">5,7</a>]. This can be further enhanced with the addition of oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a>. For example, for heel lance, the combination of oral sucrose plus skin-to-skin contact is usually sufficient. (See <a class="local">'Oral sucrose and other sweet liquids'</a> below and <a class="local">'Nonpharmacologic measures'</a> below.)</p><p>In many cases, combinations of nonpharmacologic interventions may eliminate or minimize the need for analgesic therapy thereby reducing the risk of associated side effects. (See <a class="local">'Opioid-sparing strategies'</a> below.)</p><p class="headingAnchor" id="H3226393574"><span class="h1">PROCEDURAL ANALGESIA</span><span class="headingEndMark"> — </span>The following sections outline the approach to providing analgesia and sedation for painful procedures in neonates. Details of specific pain management interventions are provided below. (See <a class="local">'Specific interventions for pain management'</a> below.)</p><p class="headingAnchor" id="H4164401663"><span class="h2">Simple procedures</span></p><p class="headingAnchor" id="H3728780471"><span class="h3">Mildly painful (heel lance, venipuncture, etc)</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Example procedures</strong> – Examples of minor simple procedures that are typically associated with mild pain include  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Heel lance or finger stick</p><p class="bulletIndent2"><span class="glyph">•</span>Venipuncture or peripheral venous catheter insertion </p><p class="bulletIndent2"><span class="glyph">•</span>Intramuscular (IM) or subcutaneous injection</p><p class="bulletIndent2"><span class="glyph">•</span>Nasogastric (NG) tube insertion</p><p class="bulletIndent2"><span class="glyph">•</span>Bladder catheterization</p><p class="bulletIndent2"><span class="glyph">•</span>Dressing change/tape removal</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Appropriate measures</strong> — For neonates undergoing brief mildly painful minor procedures, we use oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> in combination with nonpharmacologic measures (eg, skin-to-skin contact, non-nutritive sucking)  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>). (See <a class="local">'Nonpharmacologic measures'</a> below and <a class="local">'Oral sucrose and other sweet liquids'</a> below.)</p><p></p><p class="bulletIndent1">A topical anesthetic (eg, eutectic mixture of local anesthetics [EMLA]) can also be used for some procedures in this category (eg, intravenous [IV] catheter insertion, IM, or subcutaneous injection) but not others (eg, NG tube insertion, bladder catheterization, dressing change). EMLA is not routinely used for heel lance since it appears to be ineffective in this setting. (See <a class="local">'Topical anesthetics'</a> below.)</p><p></p><p class="headingAnchor" id="H1680083717"><span class="h3">Moderately painful (lumbar puncture, arterial puncture, etc)</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Example procedures</strong> – Examples of minor procedures that are associated with moderate pain include  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lumbar puncture (LP) </p><p class="bulletIndent2"><span class="glyph">•</span>Peripheral arterial puncture or catheterization</p><p class="bulletIndent2"><span class="glyph">•</span>Umbilical venous or arterial catheterization</p><p class="bulletIndent2"><span class="glyph">•</span>Intraosseous (IO) cannulation </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Appropriate measures</strong> – For neonates undergoing minor procedures associated with moderate pain, we use nonpharmacologic measures, oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a>, plus a topical anesthetic (eg, EMLA) when appropriate  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>). (See <a class="local">'Nonpharmacologic measures'</a> below and <a class="local">'Oral sucrose and other sweet liquids'</a> below and <a class="local">'Topical anesthetics'</a> below.)</p><p></p><p class="bulletIndent1">In our experience, the combination of these measures usually permits successful completion of the procedure. Rarely, a low dose of a short-acting opioid (eg, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) may be required. Caution should be used when using opioids for these procedures in nonintubated patients given the risk of respiratory depression. (See <a class="local">'Opioids'</a> below.)</p><p></p><p class="headingAnchor" id="H732439473"><span class="h2">More complex procedures</span><span class="headingEndMark"> — </span>More complex procedures are those that not only cause moderate pain, but also require that the neonate remain relatively still during the procedure. </p><p>Examples of such procedures include  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Percutaneous central venous catheter (CVC) placement </p><p class="bulletIndent1"><span class="glyph">●</span>Placement of a peripherally inserted central catheter (PICC)</p><p class="bulletIndent1"><span class="glyph">●</span>Chest tube placement</p><p></p><p>This category also includes the following procedures, which are discussed in greater detail below:</p><p class="bulletIndent1"><span class="glyph">●</span>Circumcision (see <a class="local">'Circumcision'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Endotracheal intubation (see <a class="local">'Endotracheal intubation'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Retinopathy of prematurity (ROP) examination (see <a class="local">'ROP screening examination'</a> below)</p><p></p><p class="headingAnchor" id="H218478339"><span class="h3">General approach</span><span class="headingEndMark"> — </span>For neonates undergoing more complex procedures (ie, CVC or PICC placement, chest tube insertion), we use multimodal analgesia, including <strong>all</strong> of the following  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Nonpharmacologic measures (eg, non-nutritive sucking, facilitated tucking) (see <a class="local">'Nonpharmacologic measures'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> (see <a class="local">'Oral sucrose and other sweet liquids'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Topical and/or local anesthetic when appropriate (see <a class="local">'Topical anesthetics'</a> below and <a class="local">'Local anesthesia'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">Acetaminophen</a> (see <a class="local">'Acetaminophen'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>A short-acting sedative or opioid agent (eg, <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>), if needed (see <a class="local">'Ketamine'</a> below and <a class="local">'Fentanyl'</a> below and <a class="local">'Sufentanil'</a> below)</p><p></p><p>When opioids are used for these procedures, we prefer short-acting over longer-acting agents (ie, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> or <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a> rather than <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>) because these procedures are usually brief. The amount of opioid required can be reduced by using a local anesthetic and <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a>. In our experience, this combination often allows for a successful procedure. Opioids can cause respiratory depression in neonates, especially in preterm neonates, and these agents should be used with caution in nonintubated patients. (See <a class="local">'Adverse effects'</a> below.)</p><p>The efficacy and safety of opioids for procedural analgesia/sedation in neonates has been studied in randomized trials and meta-analyses [<a href="#rid8">8,9</a>]. In a meta-analysis of three trials (199 neonates) comparing opioids (<a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, or <a class="drug drug_pediatric" data-topicid="12998" href="/d/drug information/12998.html" rel="external">remifentanil</a>) versus placebo, opioids reduced pain scores during the procedure by a mean 2.6 points on the premature infant pain profile (PIPP) score, which ranges from 0 to 21 points  (<a class="graphic graphic_table graphicRef140125" href="/d/graphic/140125.html" rel="external">table 3</a>). Episodes of apnea occurred more often in the opioid group (10 versus 3 percent), but the analysis did not detect a significant difference in desaturation episodes (11 versus 6 percent). There were no episodes of hypotension in either group and only one episode of bradycardia (in a patient receiving morphine). </p><p>In a trial not included in the above meta-analysis, intubated preterm neonates undergoing CVC placement were randomly assigned to topical anesthesia alone, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> alone, topical anesthesia plus morphine, or no specific analgesic therapy [<a href="#rid8">8</a>]. Patients treated with morphine (either alone or in combination with topical anesthesia) had lower pain scores compared with those in the topical anesthesia alone or no treatment groups. However, patients who received morphine more often required an increase in the ventilator rate for the first 12 hours following the procedure. </p><p class="headingAnchor" id="H794035874"><span class="h3">Specific procedures</span></p><p class="headingAnchor" id="H2064214268"><span class="h4">Circumcision</span><span class="headingEndMark"> — </span>Multimodal analgesia for neonatal circumcision includes oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a>, non-nutritive sucking, facilitated tucking, local anesthesia (eg, ring block or dorsal penile nerve block), and <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> for postprocedure pain. Analgesia for neonatal circumcision is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/5401.html" rel="external">"Neonatal circumcision: Techniques", section on 'Pain control'</a>.)</p><p class="headingAnchor" id="H890851906"><span class="h4">ROP screening examination</span><span class="headingEndMark"> — </span>For most neonates undergoing screening or follow-up ROP examination, we suggest the following measures [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonpharmacologic measures (eg, non-nutritive sucking, facilitated tucking) (see <a class="local">'Nonpharmacologic measures'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> (see <a class="local">'Oral sucrose and other sweet liquids'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Topical anesthetic (eg, <a class="drug drug_pediatric" data-topicid="12740" href="/d/drug information/12740.html" rel="external">proparacaine</a>), depending on ophthalmologist preference [<a href="#rid11">11</a>]</p><p></p><p>Topical anesthesia (eg, <a class="drug drug_pediatric" data-topicid="12740" href="/d/drug information/12740.html" rel="external">proparacaine</a>) reduces pain at speculum insertion, but this intervention alone may not provide sufficient analgesia for the procedure in some cases. In a meta-analysis of two trials (124 neonates), pretreatment with topical proparacaine reduced pain scores compared with no anesthesia, but a substantial subset of neonates in both groups had unacceptably high pain scores (29 versus 52 percent, respectively) [<a href="#rid12">12</a>].</p><p>For this reason, other adjunctive interventions (ie, oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> and nonpharmacologic measures such as non-nutritive sucking and/or facilitated tucking) are used in addition to topical anesthesia to reduce pain during ROP examination [<a href="#rid13">13-16</a>]. (See <a class="local">'Nonpharmacologic measures'</a> below and <a class="local">'Oral sucrose and other sweet liquids'</a> below.) </p><p>Additional analgesia/sedation is required when ROP treatment is administered during the procedure (eg, laser therapy or intravitreal injection). We typically use a short-acting agent (eg, <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) for this purpose. (See <a class="local">'Ketamine'</a> below and <a class="local">'Fentanyl'</a> below and <a class="local">'Sufentanil'</a> below.)</p><p>In a small clinical trial, intranasal <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> reduced pain scores during ROP examination [<a href="#rid17">17</a>]; however, additional studies are needed before routinely adopting this approach. </p><p class="headingAnchor" id="H1224406857"><span class="h4">Endotracheal intubation</span><span class="headingEndMark"> — </span>Commonly used agents for neonates undergoing elective tracheal intubation include [<a href="#rid18">18-20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">Ketamine</a> (the preferred agent at the author's institution) (see <a class="local">'Ketamine'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">Fentanyl</a> or other short-acting opioid (eg, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>, <a class="drug drug_pediatric" data-topicid="12998" href="/d/drug information/12998.html" rel="external">remifentanil</a>) (see <a class="local">'Fentanyl'</a> below and <a class="local">'Sufentanil'</a> below)</p><p></p><p>Though <a class="drug drug_pediatric" data-topicid="12741" href="/d/drug information/12741.html" rel="external">propofol</a> is used in some centers for endotracheal intubation in neonates, it is not used at the author's institution given the high incidence of adverse hemodynamic effects. (See <a class="local">'Propofol'</a> below.)</p><p>The combination of an opioid plus a benzodiazepine (eg, <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a>) is another alternative; however, this is associated with increased risk of adverse events and does not appear to improve the likelihood of successful intubation compared with an opioid alone [<a href="#rid21">21,22</a>]. (See <a class="local">'Midazolam'</a> below.)</p><p>In a multicenter observational study describing intubation premedication practices across 16 neonatal intensive care units (NICUs) in France, sedative/analgesic drugs were administered for approximately one-half of all neonatal intubations (including elective and emergency procedures) [<a href="#rid20">20</a>]. The most commonly used agents were <a class="drug drug_pediatric" data-topicid="12741" href="/d/drug information/12741.html" rel="external">propofol</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>, and <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a>. Factors associated with receiving premedication included type of procedure (elective versus emergency; those undergoing elective intubation were five times more likely to receive sedation) and whether the NICU had a written protocol for procedural sedation.</p><p>In an observational study of 57 preterm infants requiring intubation in the delivery room, neonates who received <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a> (1 to 2 mg/kg) in combination with <a class="drug drug_pediatric" data-topicid="12875" href="/d/drug information/12875.html" rel="external">atropine</a> had lower pain scores and were less likely to develop vagal bradycardia during intubation compared with neonates who received no analgesia [<a href="#rid23">23</a>]. In addition, the ketamine group was less likely to require vasopressor support during the NICU stay compared with the no analgesia group (8 versus 33 percent). However, given the observational nature of these data, causality cannot be inferred (in other words, it is unclear if administration of ketamine resulted in better hemodynamic stability or if the finding merely reflects that stable infants were more likely to be selected for ketamine sedation).</p><p>A randomized controlled trial involving 20 preterm newborns found that the intubating conditions were better in those receiving <a class="drug drug_pediatric" data-topicid="12998" href="/d/drug information/12998.html" rel="external">remifentanil</a> compared with <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>; neither group experienced complications from the medication [<a href="#rid18">18</a>]. In a separate trial of 71 neonates undergoing elective or semi-elective intubation who were randomly assigned to remifentanil or morphine plus <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a>, both groups had similar success rates on first attempt (75 versus 69 percent, respectively) [<a href="#rid21">21</a>]. Pain scores were modestly lower in the morphine/midazolam group (0.5 versus 2 points on a 10-point pain scale). </p><p class="headingAnchor" id="H18755732"><span class="h1">POSTOPERATIVE PAIN</span><span class="headingEndMark"> — </span>For postoperative pain, management is tailored to the specific surgical procedure. For most neonates undergoing major surgery, we use a multimodal approach to postoperative pain management including <strong>all </strong>of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonpharmacologic measures (eg, breastfeeding, skin-to-skin contact) (see <a class="local">'Nonpharmacologic measures'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Regularly scheduled <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a>, which reduces the need for opioid therapy (see <a class="local">'Acetaminophen'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent opioids as needed (see <a class="local">'Opioids'</a> below)</p><p></p><p>The available observational and clinical trial data suggest that intermittent opioid therapy is safe and effective for reducing postoperative pain in neonates and is equally effective when compared with continuous dosing [<a href="#rid24">24-26</a>]. Higher doses of opioids, particularly when administered via continuous infusion, carry an increased risk of adverse effects (eg, apnea, increased ventilator requirement, hypotension) [<a href="#rid27">27</a>]. (See <a class="local">'Adverse effects'</a> below.)</p><p>A more detailed discussion of postoperative pain management in infants and children is provided separately. (See  <a class="medical medical_review" href="/d/html/127173.html" rel="external">"Approach to the management of acute perioperative pain in infants and children"</a> and  <a class="medical medical_review" href="/d/html/94561.html" rel="external">"Pharmacologic management of acute perioperative pain in infants and children"</a>.)</p><p class="headingAnchor" id="H1761716216"><span class="h1">PROLONGED OR CHRONIC PAIN</span><span class="headingEndMark"> — </span>Examples of conditions or circumstances that may cause prolonged pain and discomfort in neonates include:</p><p class="bulletIndent1"><span class="glyph">●</span>Indwelling chest tube </p><p class="bulletIndent1"><span class="glyph">●</span>Ongoing medical condition associated with moderate to severe pain (eg, necrotizing enterocolitis, bacterial meningitis)</p><p class="bulletIndent1"><span class="glyph">●</span>Mechanical ventilation (see <a class="local">'Mechanical ventilation'</a> below)</p><p></p><p>The distinction between the terms "prolonged" and "chronic" pain is not always clear. Despite ongoing efforts, consistent definitions for these terms in neonates have not been established [<a href="#rid28">28-30</a>]. We generally use the term "prolonged pain" when referring to pain that persists beyond a simple one-time procedure but that has a limited course (eg, pain associated with an indwelling chest tube or endotracheal tube); whereas we use "chronic pain" when referring to pain that is expected to last well beyond the neonatal period (eg, epidermolysis bullosa). (See  <a class="medical medical_review" href="/d/html/15453.html" rel="external">"Overview of the management of epidermolysis bullosa", section on 'Pain and itch management'</a>.) </p><p class="headingAnchor" id="H210233312"><span class="h2">General approach</span><span class="headingEndMark"> — </span>For neonates with ongoing painful medical conditions and those who are receiving interventions that cause prolonged pain or discomfort, we use a multimodal approach to pain control that typically includes all of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonpharmacologic measures (eg, breastfeeding, skin-to-skin contact) (see <a class="local">'Nonpharmacologic measures'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">Acetaminophen</a> as needed (see <a class="local">'Acetaminophen'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent as-needed opioids (eg, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>) (see <a class="local">'Opioids'</a> below)</p><p></p><p>Most neonates are adequately managed with these measures. However, neonates with poorly controlled pain may require a continuous opioid infusion. (See <a class="local">'Opioids'</a> below.) </p><p>We generally prefer intermittent rather than continuous dosing of opioids since intermittent dosing tends to result in a lower cumulative dose and lower risk of apnea and other adverse effects. Another advantage of intermittent dosing is that it necessitates regular pain assessments for these neonates. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Pain assessment'</a>.)</p><p>Other agents that are sometimes used in the management of infants with chronic pain include <a class="drug drug_pediatric" data-topicid="12590" href="/d/drug information/12590.html" rel="external">methadone</a>, <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a>, or <a class="drug drug_pediatric" data-topicid="13330" href="/d/drug information/13330.html" rel="external">gabapentin</a> [<a href="#rid31">31</a>]. Consultation with a pain specialist is often helpful for management of these patients.</p><p class="headingAnchor" id="H2132733344"><span class="h2">Specific scenarios</span></p><p class="headingAnchor" id="H3183529292"><span class="h3">Mechanical ventilation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach</strong> – For intubated neonates receiving ongoing invasive mechanical ventilation, we use a multimodal approach to pain and sedation management, including <strong>all </strong>of the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intermittent doses of an opioid (eg, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) (see <a class="local">'Opioids'</a> below)</p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">Acetaminophen</a> as needed (see <a class="local">'Acetaminophen'</a> below)</p><p class="bulletIndent2"><span class="glyph">•</span>Nonpharmacologic measures (see <a class="local">'Nonpharmacologic measures'</a> below)</p><p></p><p class="bulletIndent1">Most neonates are adequately managed with these measures. However, neonates with poorly controlled pain or severe agitation may require continuous opioid infusion and/or the addition of a sedative agent (eg, <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> or <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a>). (See <a class="local">'Opioids'</a> below and <a class="local">'Midazolam'</a> below and <a class="local">'Dexmedetomidine'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring and titration</strong> – Opioid therapy for mechanical ventilation in neonates should be guided by routine pain/sedation assessments using a validated tool. In our practice, we use either the neonatal pain, agitation, and sedation scale (N-PASS) or COMFORTneo score for this purpose [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Pain assessment tools'</a>.)</p><p></p><p class="bulletIndent1">Pain/sedation scores should be assessed and recorded every four to eight hours and after any intervention. A target level of sedation should be specified by the care team and opioid therapy should target the desired score. For example, a typical initial target for intubated neonates is light sedation (ie, a score of -2 to -5 on the N-PASS sedation score or a score of 11 to 13 if using COMFORTneo). However, the target sedation score should be individualized according to the infant's condition, phase of illness, and clinical stability. For stable neonates who are weaning from the ventilator, it is reasonable to target a comfortably awake state (ie, N-PASS score of -1 to +3). For neonates with significant clinical instability (eg, severe pulmonary hypertension) and/or ventilator dyssynchrony, it may be appropriate to target deeper sedation (eg, N-PASS score of -6 to -10). Use of an institutional pain and sedation protocol can help ensure that intubated patients receive adequate sedation and analgesia while minimizing adverse effects of opioid therapy [<a href="#rid33">33,34</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intermittent or continuous dosing</strong> – In our practice, we generally use a stepwise approach to opioid dosing, beginning with intermittent as-needed doses and only escalating to a continuous infusion if the neonate has poorly controlled pain or agitation despite multiple intermittent doses. </p><p></p><p class="bulletIndent1">Although data comparing the two approaches are scarce, we generally prefer intermittent rather than continuous opioid dosing, when possible, for the following reasons:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intermittent dosing tends to result in a lower cumulative dose and lower risk of hypotension and other adverse effects. (See <a class="local">'Adverse effects'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intermittent dosing necessitates regular pain/sedation assessments. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Pain assessment'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For neonates requiring prolonged therapy, the risk of experiencing severe opioid withdrawal after discontinuing therapy is generally lower with intermittent dosing. </p><p></p><p class="bulletIndent1">In a multicenter observational study that included 1589 intubated neonates receiving opioid analgesia for mechanical ventilation, 41 percent received both intermittent and continuous dosing, 34 percent received only continuous infusion, and 25 percent received only intermittent doses [<a href="#rid35">35</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supporting evidence</strong> – The efficacy and safety of opioid analgesia for mechanical ventilation in neonates has been studied in clinical trials and meta-analyses [<a href="#rid36">36-39</a>]. In a meta-analysis of seven trials involving 1259 intubated neonates, the duration of mechanical ventilation was similar in patients managed with or without opioids [<a href="#rid37">37</a>]. In most trials, pain scores during the first 48 hours were lower in the opioid group, though one trial failed to detect a difference in pain scores during endotracheal suctioning. Infants in the opioid group took slightly longer to reach full enteral feeds (mean difference 1.7 days). The incidence of intraventricular hemorrhage was modestly lower in the opioid group (28 versus 34 percent), but the difference was not statistically significant (relative risk [RR] 0.84, 95% CI 0.65-1.09). Rates of other neonatal morbidities (necrotizing enterocolitis, bronchopulmonary dysplasia) were similar in both groups, as was the duration of hospitalization and 28-day mortality rate. Only two trials (n = 173) reported rates of long-term neurodevelopmental impairment, which were similar in both groups. The trials included in the meta-analysis varied considerably in the population studied (most trials enrolled only preterm neonates with various gestational age ranges; two trials enrolled preterm and term neonates), the opioid agent used (approximately half of the trials used <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, the other half used <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>), dosing regimens (most trials used continuous dosing), and the outcomes assessed. </p><p></p><p class="bulletIndent1">The safety of opioid analgesia for mechanical ventilation in neonates is also supported by observational studies [<a href="#rid35">35,40</a>]. In a multicenter observational study that included 2142 intubated neonates managed at &gt;200 neonatal intensive care units (NICUs) in Europe, 74 percent of patients received opioid analgesia during their mechanical ventilation course [<a href="#rid35">35</a>]. The most common agents were <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> (used in 58 percent of cases), <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> (40 percent), and <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a> (14 percent); some patients received more than one agent. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long-term effects</strong> – It remains uncertain whether prolonged exposure to analgesic and/or sedative medications in the neonatal period has any long-term impact on neurologic and behavioral outcomes. This issue is discussed separately. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Impact of analgesic and sedative therapy'</a>.)</p><p></p><p class="headingAnchor" id="H280155056"><span class="h3">Hypoxic-ischemic encephalopathy</span><span class="headingEndMark"> — </span>Opioid analgesia is often used to treat pain and stress in term newborns with hypoxic-ischemic encephalopathy (HIE) resulting from perinatal asphyxia. Most affected infants are managed with therapeutic hypothermia, as discussed separately. (See  <a class="medical medical_review" href="/d/html/6216.html" rel="external">"Clinical features, diagnosis, and treatment of neonatal encephalopathy", section on 'Therapeutic hypothermia'</a>.)</p><p>While data are limited, it is common practice to provide analgesia and sedation for neonates with HIE. The rationale is to reduce the discomfort and stress associated with therapeutic hypothermia and to compliment the general neuroprotective measures provided to these neonates.</p><p>At our institution, we use a continuous intravenous (IV) <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> infusion for most neonates with HIE. Other centers may use other agents (eg, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a>) [<a href="#rid41">41-43</a>]. (See <a class="local">'Morphine'</a> below and <a class="local">'Fentanyl'</a> below and <a class="local">'Dexmedetomidine'</a> below.)</p><p>Newborns with HIE often have other end-organ damage, including acute kidney injury, which may result in reduced <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> clearance [<a href="#rid44">44,45</a>]. Care should be taken to titrate morphine to effect and avoid oversedation.</p><p>It is unclear if opioids or other sedating medications improve outcomes for neonates with HIE. Clinical trials are lacking and the available observational studies have reached different conclusions [<a href="#rid46">46-50</a>]. One study reported that neonates with HIE who received opioids had less severe findings on magnetic resonance imaging (MRI) and/or higher scores on neurodevelopmental testing compared with those who did not receive opioid therapy [<a href="#rid47">47</a>]. However, another study did not detect a difference in neurodevelopmental outcomes between those who did and did not receive preemptive opioid therapy [<a href="#rid48">48</a>]. A third study found that both inadequate and excessive sedation (as measured by clinical pain/sedation scores) during therapeutic hypothermia were associated with increased risk of adverse neurologic outcome at NICU discharge [<a href="#rid49">49</a>]. An ongoing clinical trial is evaluating opioid versus <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a> sedation/analgesia in neonates with HIE [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H292112028"><span class="h3">End of life care</span><span class="headingEndMark"> — </span>Opioids are the most commonly used agents for providing comfort care at the end of life [<a href="#rid52">52</a>]. Benzodiazepines are also commonly used in this setting [<a href="#rid52">52</a>]. (See <a class="local">'Opioids'</a> below and <a class="local">'Midazolam'</a> below.)</p><p>In a retrospective study that analyzed data from nearly 20,000 neonates admitted to the NICU who died during the birth hospitalization, 31 percent received sedative and/or analgesic medications on the day of death [<a href="#rid52">52</a>]. Of these, 87 percent received opioids and 50 percent received benzodiazepines. </p><p>Palliative care in infants and children is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/6252.html" rel="external">"Pediatric palliative care"</a>.)</p><p class="headingAnchor" id="H3393673925"><span class="h1">SPECIFIC INTERVENTIONS FOR PAIN MANAGEMENT</span><span class="headingEndMark"> — </span>The following sections describe some of interventions that are used for pain control in neonates. The approach to determining which interventions are appropriate in different clinical scenarios is described above. (See <a class="local">'Procedural analgesia'</a> above and <a class="local">'Postoperative pain'</a> above and <a class="local">'Prolonged or chronic pain'</a> above.)</p><p class="headingAnchor" id="H3606820790"><span class="h2">Nonpharmacologic measures</span><span class="headingEndMark"> — </span>The following nonpharmacologic approaches can effectively reduce pain and discomfort from routine care measures and minor procedures (eg, heel lance) in both preterm and term neonates [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H2566137411"><span class="h3">Breastfeeding or breast milk</span><span class="headingEndMark"> — </span>Breastfeeding is an effective analgesic measure. Supplemental breast milk is a reasonable option for providing neonatal analgesia, but less effective than breastfeeding or <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a>/glucose [<a href="#rid54">54</a>]. Breastfeeding is a developmentally superior alternative to oral sucrose or glucose for pain control in infants. Benefits of breastfeeding include maternal proximity and ventral skin-to-skin contact, which increase beta endorphin and oxytocin levels in newborns, and the effects of sugars, fats, and other nutrients in breast milk combined with nutritive sucking to reduce pain and divert the infant's attention away from the painful stimulus. However, breastfeeding may not be possible in some situations (eg, an intubated preterm neonate undergoing a painful procedure) . (See <a class="local">'Oral sucrose and other sweet liquids'</a> below.)</p><p>The efficacy of breastfeeding for neonates undergoing painful procedures is supported by randomized trials and meta-analyses [<a href="#rid54">54-56</a>]. In one systematic review, infants who were breastfed or received breast milk were compared with control groups receiving placebo or no intervention, or interventions such as <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a>, holding by mother, non-nutritive sucking, or swaddling [<a href="#rid54">54</a>]. Patients in the breastfeeding group had lower pain scores during the procedure. A separate systematic review found that breastfeeding was more effective for reducing pain scores in full-term or preterm infants than maternal holding, maternal skin-to-skin contact, topical anesthetics, oral sucrose, or music therapy, whereas expressed breast milk did not consistently reduce pain responses [<a href="#rid56">56</a>]. One limitation of the evidence has been the significant variability in study design among trials. </p><p class="headingAnchor" id="H56988832"><span class="h3">Non-nutritive sucking</span><span class="headingEndMark"> — </span>Although breastfeeding or oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> are preferred to non-nutritive sucking for infants undergoing minor painful procedures, non-nutritive sucking is effective in reducing pain-related distress in both preterm and term infants [<a href="#rid1">1,53</a>]. Clinical trial have shown that infants offered pacifiers during painful stimuli have less intense pain responses (less crying , lower heart rate) compared with those who received no intervention or swaddling or rocking alone [<a href="#rid53">53,57</a>]. Infants who received pacifiers dipped in sucrose had greater pain relief compared with those who received a pacifier alone. (See <a class="local">'Oral sucrose and other sweet liquids'</a> below.) </p><p class="headingAnchor" id="H3536985205"><span class="h3">Other measures</span><span class="headingEndMark"> — </span>The use of the following measures alone or in combination with non-nutritive sucking or oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> is beneficial in reducing procedural pain [<a href="#rid53">53</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Swaddling or facilitated tucking</strong> – In term and preterm infants, swaddling or facilitated tucking (defined as gently maintaining the arms and legs in a flexed position) is more effective than no intervention in reducing pain responses to invasive procedures (eg, endotracheal suctioning and heel stick) [<a href="#rid53">53,58</a>]. A multicenter randomized trial showed that facilitated tucking in combination with oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> was more effective in relieving pain from repeated heel sticks compared with either intervention alone [<a href="#rid59">59</a>]. Gently keeping the infant's limbs flexed activates proprioceptive, tactile, and thermal systems; facilitates self-soothing behaviors (eg, hand-to-mouth movement, non-nutritive sucking) and is developmentally supportive. This can be achieved manually (facilitated tucking) or by swaddling in a blanket.</p><p></p><p class="bulletIndent1">Of note, tight swaddling should be avoided as this has been associated with an increased risk of developmental dysplasia of the hip. (See  <a class="medical medical_review" href="/d/html/6287.html" rel="external">"Developmental dysplasia of the hip: Epidemiology and pathogenesis", section on 'Swaddling'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Skin-to-skin contact (kangaroo care)</strong> – Skin-to-skin contact, which includes kangaroo care (with infant resting between the mother's breasts) stimulates ventral tactile and proprioceptive systems and reduces neonatal pain responses [<a href="#rid60">60-62</a>]. A systematic review reported that skin-to-skin contact was effective and safe in reducing neonatal pain due to a single painful procedure (eg, heel lance or venipuncture) [<a href="#rid63">63</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sensorial saturation</strong> – Sensorial saturation refers to providing multimodal sensory inputs (eg, touch, massage, voice, smell) during a painful procedure. Several studies have shown pain reduction in infants receiving sensorial saturation (eg, radiant warmth or exposure to familiar scent) plus oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> during painful procedures compared with oral sucrose alone [<a href="#rid4">4,64-66</a>]. However, this approach is labor-intensive, and it can be challenging to define the right amount of stimulation (too much stimulation can cause distress and sensitize the infant to pain; too little stimulation may not be effective). This fine line changes across gestational ages.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Music</strong> – Music reduces pain responses and increases physiological stability during neonatal pain, although a systematic review found that the interventions and their therapeutic effects were inconsistent [<a href="#rid67">67</a>]. A subsequent randomized, controlled, blinded crossover clinical trial in neonates &gt;32 weeks gestation found that pain scores were significantly reduced at all time points when music was combined with <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> compared with groups given music or sucrose alone, but there were no differences in scores between the music and sucrose groups [<a href="#rid68">68</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Massage</strong> – Several studies have shown that massage has therapeutic benefits for acute pain (eg, heel lance, venipuncture) in term and preterm neonates [<a href="#rid69">69-74</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unproven measures</strong> – We suggest <strong>not</strong> routinely using the following modalities for treatment of acute pain in neonates since the available studies have not consistently demonstrated a benefit [<a href="#rid75">75-80</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Therapeutic touch </p><p class="bulletIndent2"><span class="glyph">•</span>Warming </p><p class="bulletIndent2"><span class="glyph">•</span>Osteopathic manipulation </p><p class="bulletIndent2"><span class="glyph">•</span>Medical acupuncture </p><p></p><p class="headingAnchor" id="H2013100039"><span class="h2">Oral sucrose and other sweet liquids</span><span class="headingEndMark"> — </span>Oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> and other sweet-tasting liquids, such as glucose or dextrose, are effective analgesics in both term and preterm infants [<a href="#rid81">81-83</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical uses</strong> – At our institution, we use oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> solution in combination with nonpharmacologic measures (eg, skin-to-skin contact, non-nutritive sucking) to reduce minor acute episodic procedural pain (eg, venipuncture, intramuscular [IM] injection) [<a href="#rid81">81,83</a>]. Sucrose may also be combined with local anesthesia and/or opioid agents as part of multimodal analgesia for more painful, prolonged and/or invasive procedures (eg, lumbar puncture [LP], circumcision, chest tube insertion, percutaneous central venous catheter insertion, or intraosseous access)  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dosing and administration</strong> – We use a 24 percent <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> solution with weight-based dosing as follows: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>≤1000 g: 0.05 to 0.1 mL (one to two drops) </p><p class="bulletIndent2"><span class="glyph">•</span>&gt;1000 to 1500 g: 0.15 to 0.2 mL (three to four drops) </p><p class="bulletIndent2"><span class="glyph">•</span>&gt;1500 to 2000 g: 0.25 to 0.35 mL (five to seven drops)</p><p class="bulletIndent2"><span class="glyph">•</span>&gt;2000 g: 0.4 to 0.5 mL (8 to 10 drops)</p><p></p><p class="bulletIndent1">However, the optimal dose for oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> has not been established and reported dosing regimens range from 0.05 to 1 mL of a 24 percent sucrose solution [<a href="#rid1">1,81,84-86</a>]. </p><p></p><p class="bulletIndent1"><a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">Sucrose</a> can be administered orally via a syringe or onto the tongue by allowing the infant to suck on a pacifier that has been previously dipped in a sucrose solution. For intubated infants, we place sucrose directly on the infant's tongue.</p><p></p><p class="bulletIndent1">We prescribe and track <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> as a medication [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing</strong> – We administer oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> one to two minutes before a painful procedure, and repeat the dose as needed for pain relief. Multiple resources recommend an interval of two minutes after sucrose therapy before performing the procedure [<a href="#rid87">87</a>], although one randomized trial suggested that it may not be necessary to wait after sucrose administration [<a href="#rid88">88</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Repeat doses</strong> – If needed, we repeat <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> doses during the procedure rather than waiting until after the procedure. In our experience, we have found that additional doses given during the procedure are beneficial [<a href="#rid85">85,89</a>], though one study found little difference in pain scores between infants who received one dose two minutes before a heel stick and those who received a dose before and after the procedure [<a href="#rid90">90</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adverse effects</strong> – Short-term adverse effects appear to be negligible [<a href="#rid91">91</a>]. It is uncertain if there are any long-term adverse effects of repeated oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> on neurodevelopment. A systematic review identified three trials that reported long-term neurodevelopmental outcomes for infants enrolled in trials of oral sucrose for neonatal procedural pain control [<a href="#rid91">91</a>]. Two trials found that repeated sucrose therapy was not associated with adverse neurodevelopmental outcome, while one trial involving preterm neonates &lt;31 weeks gestation found that receiving &gt;10 doses of oral sucrose per day during the first week of life was associated with increased risk of adverse neurodevelopmental outcome [<a href="#rid86">86,91</a>]. However, this observation has been questioned, and there has not been subsequent supportive evidence confirming this finding [<a href="#rid92">92</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy </strong>– The efficacy of <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> and other sweet-tasting liquids for preventing and reducing pain in neonates has been demonstrated in randomized trials and meta-analyses including infants with gestational ages (GA) from 25 to 42 weeks [<a href="#rid81">81-83</a>]. In meta-analyses that included &gt;100 clinical trials involving neonates undergoing painful procedures (eg, heel lance, venipuncture, intramuscular [IM] injection), oral sucrose reduced crying time and pain scores during and after the procedure [<a href="#rid81">81,82</a>]. For example, in a trial using the premature infant pain profile (PIPP) which ranges from 0 to 21 points  (<a class="graphic graphic_table graphicRef140125" href="/d/graphic/140125.html" rel="external">table 3</a>), oral sucrose reduced the PIPP score on average by one to three points [<a href="#rid93">93</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mode of action</strong> – The mode of action for <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> remains unclear. It is thought that the analgesic effects of sucrose are mediated by endogenous opioid and endorphin pathways triggered by the sweet taste. However, data supporting this theory are scant [<a href="#rid94">94,95</a>].</p><p></p><p class="headingAnchor" id="H1359624404"><span class="h2">Topical anesthetics</span><span class="headingEndMark"> — </span>Topical anesthetics are safe and effective for reducing procedural pain in neonates [<a href="#rid96">96</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical uses </strong>– Topical anesthetics are appropriate for use prior to minor dermal procedures (eg, venipuncture, IM injection, lumbar puncture [LP], circumcision)  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>). (See <a class="local">'Simple procedures'</a> above.)</p><p></p><p class="bulletIndent1">The use of topical anesthetics for neonatal circumcision is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5401.html" rel="external">"Neonatal circumcision: Techniques", section on 'Local topical anesthetics'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Agents</strong> – Commonly used topical anesthetics include <a class="drug drug_pediatric" data-topicid="12553" href="/d/drug information/12553.html" rel="external">lidocaine-prilocaine</a> (eg, EMLA [an acronym for "eutectic mixture of local anesthetics"]) and <a class="drug drug_pediatric" data-topicid="12828" href="/d/drug information/12828.html" rel="external">tetracaine</a> (amethocaine) gel (eg, Ametop). EMLA is the topical anesthetic of choice in our center. It is the agent most widely used most extensively studied in neonates. Tetracaine gel is not available in the United States.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lidocaine-prilocaine</strong><strong> cream (eg, EMLA)</strong> – EMLA is a mixture of 2.5% <a class="drug drug_pediatric" data-topicid="12551" href="/d/drug information/12551.html" rel="external">lidocaine</a> and 2.5% <a class="drug drug_general" data-topicid="10228" href="/d/drug information/10228.html" rel="external">prilocaine</a> in a cream base. It produces anesthesia within 40 to 60 minutes of its application, and the effects last for one to two hours. The term "eutectic" refers to a mixture of substances with a lower melting point than any of the individual constituents alone.</p><p></p><p class="bulletIndent2">EMLA is administered by applying 0.5 to 1 g to the site one hour prior to the procedure and covering with an occlusive dressing [<a href="#rid97">97,98</a>]. The lower end of this dose range is appropriate for preterm neonates &lt;37 weeks gestation. The maximum dose per 24-hour period should not exceed 1 g, and the application time should not exceed one hour.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tetracaine</strong><strong> (amethocaine) gel</strong> – A 4% <a class="drug drug_pediatric" data-topicid="12828" href="/d/drug information/12828.html" rel="external">tetracaine</a> (amethocaine) gel (eg, Ametop), where available, is a reasonable alternative to EMLA cream. Tetracaine gel produces anesthesia within 30 minutes of application, and the effect lasts for four to six hours. </p><p></p><p class="bulletIndent2">It is administered by applying 0.5 g to the site 30 minutes before the procedure and covering with an occlusive dressing.</p><p></p><p class="bulletIndent2"><a class="drug drug_pediatric" data-topicid="12828" href="/d/drug information/12828.html" rel="external">Tetracaine</a> gel should <strong>not</strong> be used in extremely preterm neonates since rare systemic side effects (eg, arrhythmia) have been reported [<a href="#rid99">99</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supporting evidence</strong> – The evidence supporting EMLA and <a class="drug drug_pediatric" data-topicid="12828" href="/d/drug information/12828.html" rel="external">tetracaine</a> (amethocaine) gel for minor dermal procedures in neonates comes from observational studies and several small randomized trials, which reached variable conclusions [<a href="#rid96">96-98,100-103</a>]. A systematic review identified seven small trials (n = 574 neonates) comparing either EMLA or tetracaine gel to placebo [<a href="#rid96">96</a>]. For EMLA, two trials reported reduced pain scores during venipuncture or LP, whereas three trials found little to no difference in pain scores during heel lance [<a href="#rid96">96</a>]. For tetracaine gel, one trial reported reduced pain scores during venipuncture, whereas a second trial found little to no difference in pain scores during intramuscular injection [<a href="#rid96">96</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adverse effects</strong> – Topical anesthetics are generally well tolerated in neonates when used at appropriate doses. The most common adverse effects reported in the available trials were minor local skin reactions; no serious adverse events were reported [<a href="#rid96">96</a>]. Repeated or frequent doses should be avoided as this increases the risk for systemic absorption and toxicity. In addition, topical anesthetics should <strong>not</strong> be applied on open wounds or lacerations. A potential rare adverse effect of topical anesthetics is methemoglobinemia, which is discussed separately. (See  <a class="medical medical_review" href="/d/html/7094.html" rel="external">"Methemoglobinemia", section on 'Topical anesthetics'</a>.)</p><p></p><p>The use of topical anesthetics in older children is reviewed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/6338.html" rel="external">"Clinical use of topical anesthetics in children"</a>.)</p><p class="headingAnchor" id="H928469548"><span class="h2">Local anesthesia</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="12551" href="/d/drug information/12551.html" rel="external">Lidocaine</a> is the agent most commonly used for local anesthesia in neonates.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical uses</strong> – <a class="drug drug_pediatric" data-topicid="12551" href="/d/drug information/12551.html" rel="external">Lidocaine</a> is injected locally to reduce the pain associated with arterial puncture, percutaneous central venous catheter (CVC) placement, LP, chest tube insertion, and circumcision  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>). Lidocaine infiltration is also commonly used during surgical procedures. (See <a class="local">'Moderately painful (lumbar puncture, arterial puncture, etc)'</a> above and <a class="local">'More complex procedures'</a> above.)</p><p></p><p class="bulletIndent1">The use of topical anesthetics for neonatal circumcision is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5401.html" rel="external">"Neonatal circumcision: Techniques", section on 'Local topical anesthetics'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dosing and administration</strong> – <a class="drug drug_pediatric" data-topicid="12551" href="/d/drug information/12551.html" rel="external">Lidocaine</a> is usually administered as either a 0.5 mL/kg subcutaneous infiltration of a 1 percent (10 mg/mL) solution <strong>or</strong> 0.25 mL/kg infiltration of a 2 percent (20 mg/mL) solution. The maximum dose is 3 to 5 mg/kg. In neonates, the combination of lidocaine with <a class="drug drug_pediatric" data-topicid="13272" href="/d/drug information/13272.html" rel="external">epinephrine</a> should be <strong>avoided</strong> to minimize the risk of tissue necrosis and tachyarrhythmias. Needle-free devices are available to inject lidocaine subcutaneously in infants younger than three months of age [<a href="#rid104">104</a>].</p><p></p><p class="headingAnchor" id="H34852831"><span class="h2">Acetaminophen</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical uses</strong> – <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">Acetaminophen</a> (paracetamol) is a weak analgesic which is <strong>not</strong> effective enough to treat acute severe pain if used without other agents [<a href="#rid105">105-108</a>]. In our center, we use acetaminophen in the following settings:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For postoperative or postprocedural pain – We use <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> in combination with opioids  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>), since this reduces the amount of opioids required (ie, opioid-sparing effect) [<a href="#rid109">109,110</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For mild to moderate inflammatory pain (eg, enteropathy or necrotizing enterocolitis, skin wounds, bedsores, or nasal trauma due to noninvasive ventilation). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For musculoskeletal pain (eg, limb bruises, clavicle fractures, cephalohematoma following birth trauma). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dosing and administration</strong> – Oral, intravenous (IV), and rectal formulations of <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> are available for use in neonates [<a href="#rid111">111-114</a>]. We generally use oral dosing for neonates who can tolerate oral medication and IV dosing for those who cannot. We do not routinely use rectal acetaminophen at our center.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Oral </strong><strong>acetaminophen</strong> – Oral dosing varies by GA:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>&lt;32 weeks gestation – 15 mg/kg/dose every 12 hours</p><p class="bulletIndent3"><span class="glyph">-</span>32 to 36 weeks gestation – 15 mg/kg/dose every eight hours</p><p class="bulletIndent3"><span class="glyph">-</span>Term infants – 15 mg/kg/dose every six hours </p><p></p><p class="bulletIndent2">These doses and dosing intervals were primarily based upon antipyretic dose-response studies. In both preterm and term infants, the clearance of <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> is slower than in older children, so repeat dosing is required less frequently [<a href="#rid111">111,115,116</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>IV </strong><strong>acetaminophen</strong> – Data are limited for IV dosing of <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> in neonates [<a href="#rid117">117</a>]. We use the following dosing schedule for IV acetaminophen for infants with postmenstrual age (PMA) between 32 and 44 weeks: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Loading dose of 20 mg/kg</p><p class="bulletIndent3"><span class="glyph">-</span>Maintenance doses of 10 mg/kg starting six hours after the loading dose, and every six hours thereafter</p><p></p><p class="bulletIndent2">For neonates with PMA between 28 to 31 weeks, the dosing interval for maintenance doses is increased to 12 hours [<a href="#rid118">118</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rectal </strong><strong>acetaminophen</strong><strong> </strong>–<strong> </strong>When <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> is administered rectally, it is generally given at the same dose as for oral administration, though the optimal dosing is not established in neonates. As previously mentioned, we do not use rectal acetaminophen at our center. Other centers may use rectal acetaminophen for adjunctive analgesia in neonates who cannot receive oral therapy [<a href="#rid119">119,120</a>]. We generally prefer IV acetaminophen for this purpose. In one study, rectal acetaminophen showed minimal opioid-sparing effects on postoperative pain in neonates and infants, possibly due to inadequate rectal absorption [<a href="#rid119">119</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Total daily dose</strong> – Recommended total daily doses are based on GA and postnatal age [<a href="#rid121">121</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>24 to 30 weeks GA – 20 to 30 mg/kg/day</p><p class="bulletIndent3"><span class="glyph">-</span>31 to 36 weeks GA – 35 to 50 mg/kg/day</p><p class="bulletIndent3"><span class="glyph">-</span>37 to 42 weeks GA – 50 to 60 mg/kg/day</p><p class="bulletIndent3"><span class="glyph">-</span>1 to 3 months postnatal age– 60 to 75 mg/kg/day</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Opioid-sparing effect</strong> – For patients with postoperative pain, <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> reduces the overall amount of opioid required (ie, it has an opioid-sparing effect) [<a href="#rid120">120,122-125</a>]. In a randomized trial involving 71 neonates who underwent noncardiac thoracic or abdominal surgery, those who received regularly scheduled IV acetaminophen required less total <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> during the first 48 hours (median cumulative dose 121 versus 357 micrograms/kg) [<a href="#rid122">122</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adverse effects</strong> – <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">Acetaminophen</a> is generally well-tolerated in neonates. Rare adverse events include hepatic or kidney toxicity [<a href="#rid126">126,127</a>]. While acetaminophen is effective for temperature reduction in febrile infants, the available evidence suggests it does <strong>not</strong> increase the risk of hypothermia in neonates who are normothermic [<a href="#rid128">128</a>]. </p><p></p><p class="bulletIndent1">The long-term safety of IV <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> was demonstrated in a five-year follow-up study of infants who required neonatal intensive care [<a href="#rid129">129</a>]. Rates of various childhood health conditions (eg, asthma, atopic dermatitis, inflammatory bowel disease, autism, speech disorders, or cerebral palsy) were similar in children exposed to IV acetaminophen in the neonatal period compared with those who were not exposed.</p><p></p><p class="headingAnchor" id="H3570901373"><span class="h2">Nonsteroidal anti-inflammatory drugs (not recommended)</span><span class="headingEndMark"> — </span>Nonsteroidal anti-inflammatory drugs (NSAIDs; eg, <a class="drug drug_pediatric" data-topicid="13371" href="/d/drug information/13371.html" rel="external">ibuprofen</a>, <a class="drug drug_pediatric" data-topicid="13402" href="/d/drug information/13402.html" rel="external">ketorolac</a>, <a class="drug drug_pediatric" data-topicid="13380" href="/d/drug information/13380.html" rel="external">indomethacin</a>) are <strong>not</strong> routinely used in the management of pain in neonates since safer and effective alternative agents are available. In infants &lt;3 months old, NSAIDs have an unacceptably high risk of adverse effects (eg, gastrointestinal bleeding, platelet dysfunction, postoperative bleeding, acute kidney injury) that precludes using these agents routinely for neonatal analgesia [<a href="#rid130">130,131</a>].</p><p>Use of NSAIDs in neonates is largely limited to treatment of patent ductus arteriosus, as discussed separately. (See  <a class="medical medical_review" href="/d/html/15814.html" rel="external">"Patent ductus arteriosus (PDA) in preterm infants: Management and outcome", section on 'Pharmacologic therapy'</a>.)</p><p class="headingAnchor" id="H1772053409"><span class="h2">Opioids</span><span class="headingEndMark"> — </span>Opioids are highly effective for treating moderate to severe pain in patients of all ages. Opioids provide both analgesia and sedation, have a wide therapeutic window, and attenuate physiologic stress responses. However, the benefits of opioid therapy need to be balanced against the risk of serious adverse effects, including respiratory depression, hypotension, urinary retention, and reduced gastrointestinal motility [<a href="#rid37">37,132</a>]. </p><p>In neonates, opioids are most commonly used for postoperative pain control following major surgery, to facilitate mechanical ventilation, or for sedation/analgesia in neonates with hypoxic-ischemic encephalopathy. Opioids are also used for procedural sedation and analgesia for invasive procedures such as CVC placement, tracheal intubation, or chest tube placement. (See <a class="local">'Mechanical ventilation'</a> above and <a class="local">'Postoperative pain'</a> above and <a class="local">'Hypoxic-ischemic encephalopathy'</a> above and <a class="local">'More complex procedures'</a> above.)</p><p>In most situations, we use intermittent dosing of opioids rather than continuous IV infusions. This approach is in accordance with the American Academy of Pediatrics (AAP) and the Canadian Pediatric Society (CPS) guidelines on pain in neonates [<a href="#rid1">1</a>]. </p><p class="headingAnchor" id="H88201071"><span class="h3">Opioid-sparing strategies</span><span class="headingEndMark"> — </span>Because neonates are at increased risk of experiencing adverse effects from opioids, especially respiratory depression, the pain management approach should utilize multimodal interventions aimed at minimizing the amount of opioid required. This includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Concomitant use of <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a>. (See <a class="local">'Acetaminophen'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> and nonpharmacologic measures to address pain and discomfort (eg, non-nutritive sucking, swaddling). (See <a class="local">'Nonpharmacologic measures'</a> above and <a class="local">'Oral sucrose and other sweet liquids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of standardized pain management protocols that include routine pain assessments and nursing-driven protocols [<a href="#rid109">109,133</a>]. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Routine standardized approach'</a>.)</p><p></p><p>Limited data suggested that for neonates with postoperative pain, nurse-controlled analgesia may reduce opioid requirements compared with a continuous opioid infusion [<a href="#rid134">134,135</a>]. (See  <a class="medical medical_review" href="/d/html/94561.html" rel="external">"Pharmacologic management of acute perioperative pain in infants and children", section on 'Patient-controlled analgesia in children'</a>.)</p><p class="headingAnchor" id="H719243744"><span class="h3">Agents</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">Morphine</a> and <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> are the most commonly used opioids in neonates [<a href="#rid35">35</a>]. More potent (eg, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) and shorter-acting (eg, <a class="drug drug_pediatric" data-topicid="12998" href="/d/drug information/12998.html" rel="external">remifentanil</a>) agents are also being used with increasing frequency [<a href="#rid35">35,136</a>]. </p><p class="headingAnchor" id="H2242045676"><span class="h4">Morphine</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">Morphine</a> is the prototypical opioid and is widely used for pain management in infants, children, and adults. The onset of analgesia after a single IV dose of morphine is rapid (within five minutes) with the peak effect occurring within 10 to 20 minutes. The analgesic effect lasts for approximately four hours. The half-life of morphine is longer in neonates compared with older infants and children due to reduced protein binding.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Single or intermittent doses</strong> – We start at the minimum dose possible and increase the dose, if needed, based on serial pain assessments. Initial dosing is based on GA, as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>&lt;32 weeks GA: 5 micrograms (mcg)/kg per dose IV every four to eight hours, as needed based on pain assessment</p><p class="bulletIndent2"><span class="glyph">•</span>≥32 weeks GA: 10 mcg/kg per dose every four to eight hours, as needed based on pain assessment </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Continuous infusion</strong> – We start at the minimum dose and increase the dose, if needed, based on serial pain assessments. The initial dose for continuous IV <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> is based on GA is as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>GA &lt;32 weeks: 5 mcg/kg per hour IV</p><p class="bulletIndent2"><span class="glyph">•</span>GA ≥32 weeks: 10 mcg/kg per hour IV</p><p></p><p class="headingAnchor" id="H3039535779"><span class="h4">Fentanyl</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">Fentanyl</a> is a synthetic opioid that is 50 to 100 times more potent than <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>. It has rapid onset (within two to three minutes) and relatively short duration of action (30 to 45 minutes), making it an attractive option for procedural sedation/analgesia.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Single or intermittent doses</strong> – <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">Fentanyl</a> is given via slow IV push every two to four hours as needed based on pain assessment. Dosing is based on GA, as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>GA &lt;28 weeks – 1 to 2 mcg/kg per dose</p><p class="bulletIndent2"><span class="glyph">•</span>GA 28 to 32 weeks – 2 to 3 mcg/kg per dose</p><p class="bulletIndent2"><span class="glyph">•</span>GA &gt;32 weeks – 3 to 4 mcg/kg per dose</p><p></p><p class="bulletIndent1">When using <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> for procedural sedation/analgesia, the procedurist should wait one to three minutes after administration prior to starting the procedure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Continuous infusion</strong> – <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">Fentanyl</a> infusion is started at 0.5 to 1 mcg/kg per hour IV. The same dose is used for preterm and term neonates. We typically start at the lower dose and increase the dose if needed based on serial pain assessments. </p><p></p><p class="headingAnchor" id="H1763341192"><span class="h4">Sufentanil</span><span class="headingEndMark"> — </span>Like <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a> is a synthetic opioid that is substantially more potent than <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>. Sufentanil is approximately 10 times more potent than fentanyl. It has rapid onset (within two to three minutes) and short duration of action (20 to 30 minutes), making it an attractive option for procedural sedation/analgesia.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Single or intermittent doses</strong> – <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">Sufentanil</a> is given via slow IV push every two to four hours as needed based on pain assessment. Dosing is based on GA, as follows: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>&lt;28 weeks GA – 0.1 to 0.2 mcg/kg per dose </p><p class="bulletIndent2"><span class="glyph">•</span>≥28 weeks GA – 0.2 to 0.3 mcg/kg per dose</p><p></p><p class="bulletIndent1">When using <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a> for procedural sedation/analgesia, the procedurist should wait one to three minutes after administration prior to starting the procedure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Continuous infusion</strong> – <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">Sufentanil</a> infusion is started at 0.05 to 0.1 mcg/kg per hour IV. The same dose is used for preterm and term neonates. We typically start at the lower dose and increase the dose if needed based on serial pain assessments. </p><p></p><p class="headingAnchor" id="H3808955933"><span class="h3">Supporting evidence</span><span class="headingEndMark"> — </span>The evidence supporting use of opioids in neonates in different clinical circumstances is summarized above:</p><p class="bulletIndent1"><span class="glyph">●</span>Procedural sedation/analgesia (see <a class="local">'General approach'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>Elective endotracheal intubation (see <a class="local">'Endotracheal intubation'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>Ongoing invasive mechanical ventilation (see <a class="local">'Mechanical ventilation'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>Hypoxic-ischemic encephalopathy (see <a class="local">'Hypoxic-ischemic encephalopathy'</a> above)</p><p></p><p class="headingAnchor" id="H1240517039"><span class="h3">Comparison of agents</span><span class="headingEndMark"> — </span>Most of the comparative studies on different opioid agents in neonates have compared <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> versus <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>. There are few data comparing these agents to other opioids (eg, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>, <a class="drug drug_pediatric" data-topicid="12998" href="/d/drug information/12998.html" rel="external">remifentanil</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Analgesic effects</strong> – In the available clinical trials, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> and <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> were equally effective in reducing pain scores in intubated patients and in patients undergoing invasive procedures [<a href="#rid9">9,37,137</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk of adverse effects</strong> – Some studies suggest that the risk of adverse effects (eg, apnea, hypotension, gastrointestinal dysmotility) is higher with <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> compared with <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> [<a href="#rid137">137,138</a>]. (See <a class="local">'Adverse effects'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk of withdrawal</strong> – In studies of neonates exposed to <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> or <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> for prolonged periods (eg, patients managed on extracorporeal membrane oxygenation), the risk of clinically significant opioid withdrawal was lower with morphine [<a href="#rid139">139,140</a>]. </p><p></p><p class="headingAnchor" id="H3335402761"><span class="h3">Adverse effects</span><span class="headingEndMark"> — </span>Adverse effects associated with opioids include respiratory depression, hypotension, reduced gastrointestinal motility (which can delay establishment of enteral feeding), and urinary retention [<a href="#rid132">132</a>]. The risk of experiencing adverse effects increases with decreasing gestational age. Extremely preterm neonates &lt;26 weeks gestation are at particularly high risk of developing hypotension from opioid therapy [<a href="#rid141">141</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory depression</strong> – When used for procedural sedation/analgesia, opioids can cause respiratory depression and apnea, particularly in preterm neonates [<a href="#rid9">9</a>]. In mechanically ventilated neonates, use of continuous opioid infusions (eg, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>) modestly prolongs duration of mechanical ventilation compared with no opioid analgesia [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypotension </strong>– All opioids can cause hypotension, particularly in at-risk neonates. However, synthetic opioids (<a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) cause less histamine release and therefore tend to cause less hemodynamic instability when compared with <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> [<a href="#rid137">137</a>]. Caution must be exercised if using opioid therapy (intermittent or continuous) in patients with hypotension at baseline and in extremely preterm neonates &lt;26 weeks gestation, since these neonates are prone to low blood pressure, which can be exacerbated by opioids [<a href="#rid141">141</a>]. (See  <a class="medical medical_review" href="/d/html/109813.html" rel="external">"Assessment and management of low blood pressure in extremely preterm infants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Feeding difficulties</strong> – In mechanically ventilated neonates, use of continuous opioid infusions (eg, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>) is associated with delayed establishment of full enteral feeding compared with no opioid analgesia [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dependence and withdrawal</strong> – With prolonged exposure to opioids (≥5 to 7 days), patients begin to develop tolerance and chemical dependence, which can cause withdrawal symptoms upon discontinuation of therapy [<a href="#rid140">140</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest wall rigidity (rare)</strong> – Chest wall rigidity is a rare life-threatening complication of synthetic opioids (eg, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>, <a class="drug drug_pediatric" data-topicid="12998" href="/d/drug information/12998.html" rel="external">remifentanil</a>) [<a href="#rid142">142</a>]. (See  <a class="medical medical_review" href="/d/html/82857.html" rel="external">"Pediatric procedural sedation: Pharmacologic agents", section on 'Fentanyl'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long-term effects</strong> – It is unclear if exposure to opioids in the neonatal period has any long-term effects of neurodevelopment. This issue is discussed separately. (See  <a class="medical medical_review" href="/d/html/5021.html" rel="external">"Assessment of pain in neonates", section on 'Impact of analgesic and sedative therapy'</a>.) </p><p></p><p class="headingAnchor" id="H1545875355"><span class="h2">Sedatives</span><span class="headingEndMark"> — </span>Sedative drugs (eg, benzodiazepines, <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a>, <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a>, <a class="drug drug_pediatric" data-topicid="12741" href="/d/drug information/12741.html" rel="external">propofol</a>) play a limited role in NICU practice. </p><p class="headingAnchor" id="H2971621063"><span class="h3">Midazolam</span><span class="headingEndMark"> — </span>While <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> is generally considered a short-acting benzodiazepine, its sedating effects tend to be prolonged in neonates, particularly critically ill preterm neonates. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical uses</strong> – Use of <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> in the NICU setting is generally limited to the following circumstances:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mechanically ventilated neonates with severe agitation that is refractory to other measures (eg, significant ventilator dyssynchrony not controlled by opioids). (See <a class="local">'Mechanical ventilation'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mechanically ventilated neonates with severe pulmonary hypertension (eg, persistent pulmonary hypertension of the newborn [PPHN], congenital diaphragmatic hernia [CDH]). (See  <a class="medical medical_review" href="/d/html/135094.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Management and outcome", section on 'Sedation and neuromuscular blockade'</a> and  <a class="medical medical_review" href="/d/html/4963.html" rel="external">"Congenital diaphragmatic hernia in the neonate", section on 'Sedation and neuromuscular blockade'</a>.)</p><p></p><p class="bulletIndent1"><a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">Midazolam</a> is <strong>not </strong>used for procedural sedation in nonintubated neonates because the risk of apnea and/or desaturation is unacceptably high [<a href="#rid22">22</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dosing</strong> – We generally administer <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> via continuous IV infusion. The initial dose is 5 to 10 mcg/kg per hour. We start at the lower end of the dose range and increase if necessary to control agitation. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Data on efficacy and safety</strong> – <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">Midazolam</a> is an effective sedative agent for mechanically ventilated neonates; data are mixed regarding its safety in this setting [<a href="#rid40">40,143-146</a>]. </p><p></p><p class="bulletIndent1">Two small trials involving preterm neonates demonstrated that <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> effectively increased sedation levels compared with placebo [<a href="#rid144">144,145</a>]. There were no serious adverse hemodynamic or respiratory events noted in either trial, though the trials were likely underpowered to detect a difference. In a separate trial that randomly assigned 67 intubated preterm neonates to continuous midazolam infusion, continuous <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a> infusion, or placebo, patients in the midazolam and morphine groups had similar comfort scores during drug infusion [<a href="#rid143">143</a>]. However, at 28 days, more infants in the midazolam group had poor neurologic outcome (defined as death, severe intraventricular hemorrhage [IVH], or periventricular leukomalacia) compared with those in the morphine or placebo groups (32 versus 4 and 24 percent, respectively). While this study suggests that midazolam may adversely impact neurologic outcome, the small number of events (3 deaths and 8 severe IVHs in total) precludes drawing firm conclusions.</p><p></p><p class="bulletIndent1">By contrast, in an observational study that included 922 intubated preterm neonates receiving sedation with continuous opioid and/or <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> infusions during the initial episode of mechanical ventilation was associated with improved survival with similar rates of moderate or severe sensorimotor impairments at age two years compared with not receiving midazolam or opioids [<a href="#rid40">40</a>]. </p><p></p><p class="bulletIndent1">Accumulating data in newborn animal models suggests that <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> induces apoptosis and/or necrosis of neurons and other brain cells in the developing brain [<a href="#rid147">147</a>]. These data add to our concerns regarding the long-terms effects of routinely using midazolam for sedation in term and preterm newborns in NICU. </p><p></p><p class="headingAnchor" id="H436420213"><span class="h3">Ketamine</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">Ketamine</a> is widely used for procedural, operative, and postoperative analgesia and sedation in infants and children. It is an N-methyl-D-aspartate receptor antagonist, sometimes described as a "dissociative sedative". It has sedative, analgesic, and amnestic properties. A unique property of ketamine that distinguishes it from other sedatives and opioids is that it usually does not cause respiratory depression or hypotension. It also has bronchodilating effects. When given in the usual dosing range (1 to 2 mg/kg), ketamine produces mild increases in heart rate and blood pressure [<a href="#rid148">148</a>]. However, higher doses can because reduced heart rate and/or low blood pressure [<a href="#rid149">149,150</a>]. </p><p>Because of its favorable cardiorespiratory side effect profile, <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a> is an attractive alternative to opioids for procedural sedation, particularly in neonates with hemodynamic instability. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical uses</strong> – At our institution, we use <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a> for neonates undergoing:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elective endotracheal intubation (see <a class="local">'Endotracheal intubation'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>CVC placement (see <a class="local">'More complex procedures'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dosing </strong>– <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">Ketamine</a> is given at a dose of 1 to 2 mg/kg per dose IV.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Data on efficacy and safety </strong>– The safety and efficacy of <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a> in neonates is largely supported by observational data [<a href="#rid20">20,23,151</a>]; there are limited clinical trial data [<a href="#rid152">152,153</a>]. A single small randomized trial compared ketamine versus <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> in infants undergoing laser therapy for retinopathy of prematurity (ROP) [<a href="#rid152">152</a>]. However, the drug regimens provided insufficient analgesia for most infants in both arms, prompting the investigators to change the study protocol midway through the trial. Thus, it is difficult to interpret the results. Infants in the ketamine group less frequently experienced apnea during or after the procedure (4 versus 10 percent) and less frequently required supplemental oxygen during or after the procedure (11 versus 20 percent).</p><p></p><p class="bulletIndent1">In a single-center retrospective study of 72 infants (mean gestational age 32 weeks; mean postnatal age 7 weeks) who received <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a> (0.5 to 2 mg/kg) plus <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> (2 mcg/kg) for sedation for ultrasound-guided CVC placement, the procedural success rate was 100 percent [<a href="#rid151">151</a>]. Respiratory complications were uncommon and included need for supplemental oxygen (15 percent) and apnea (3 percent). Of the 35 infants who were breathing spontaneously during the procedure, none required intubation. No infants experienced hypotension or other adverse hemodynamic effects.</p><p></p><p class="headingAnchor" id="H2455901617"><span class="h3">Dexmedetomidine</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">Dexmedetomidine</a> is a selective alpha-2 adrenergic receptor agonist that provides sedative and mild analgesic effects. Like <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a>, but unlike most other sedatives, it causes minimal respiratory depression. Unlike ketamine, it can cause clinically significant hemodynamic effects, especially bradycardia [<a href="#rid154">154,155</a>]. The risk of bradycardia is highest in extremely low birthweight (&lt;1000 g) infants [<a href="#rid156">156</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical uses</strong> – We use <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a> as a second-line option for intubated neonates with the same clinical indications as for <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> (ie, refractory agitation, ventilator dyssynchrony, PPHN, CDH). (See <a class="local">'Mechanical ventilation'</a> above and <a class="local">'Midazolam'</a> above.)</p><p></p><p class="bulletIndent1">Adjunctive <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a> is particularly advantageous in neonates requiring prolonged mechanical ventilation, as it may help reduce opioid withdrawal and facilitate extubation in this setting [<a href="#rid157">157,158</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dosing</strong> – <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">Dexmedetomidine</a> is administered as a continuous IV infusion. Our suggested dosing for continuous infusion depends on GA:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>GA &lt;37 weeks: Starting dose of 0.2 mcg/kg per hour IV (maximum dose 1.4 mcg/kg per hour).</p><p class="bulletIndent2"><span class="glyph">•</span>GA ≥37 weeks: Starting dose of 0.4 mcg/kg per hour IV (maximum dose 1.4 mcg/kg per hour).</p><p></p><p class="bulletIndent1">We typically do not administer a loading dose since it can cause bradycardia. However, other centers do start with a loading dose (0.05 to 0.2 mcg/kg); the risk of bradycardia can be reduced by administering the loading dose slowly (over 20 to 30 minutes). Rapid IV boluses should be <strong>avoided</strong>, as this can cause severe bradycardia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Data on efficacy and safety</strong> – There are limited data on the safety and efficacy of <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a> in neonates [<a href="#rid156">156,158-160</a>]. In a small multicenter dose-finding clinical trial involving 42 intubated preterm and term infants randomly assigned to different dosing regimens of dexmedetomidine, 10 percent of patients required additional <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> while on dexmedetomidine and 40 percent required additional analgesic medications (<a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a> or <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>) [<a href="#rid159">159</a>]. Serious adverse events related to dexmedetomidine occurred in 5 percent of patients; none required discontinuation of the drug.</p><p></p><p class="bulletIndent1">A systematic review identified six studies (the clinical trial described above, a small placebo-controlled trial, plus four observational studies) describing the use of <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a> in 252 neonates [<a href="#rid158">158</a>]. All six studies reported that dexmedetomidine provided adequate sedation in most neonates. Dexmedetomidine was associated with shorter duration of mechanical ventilation and lower requirement for adjunctive sedation compared with control or opioid analgesia alone. Three studies reported no major adverse events; one study reported bradycardia as an uncommon occurrence (5 percent of patients); while one study reported that up to 40 percent of patients treated with dexmedetomidine experienced bradycardia and/or hypotension. The differences in rates of adverse events in these studies may be explained by differences in the populations studied (bradycardia is more likely in more preterm neonates) and dosing regimens used (bradycardia is more likely with higher doses, particularly if a loading dose is given). </p><p></p><p class="headingAnchor" id="H2968766391"><span class="h3">Propofol</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="12741" href="/d/drug information/12741.html" rel="external">Propofol</a> is a sedative hypnotic agent that produces deep sedation/anesthesia with amnesia. It does <strong>not</strong> provide analgesia. Thus, patients undergoing painful procedures under propofol sedation generally require additional medication(s) for pain control. </p><p>In older infants and children, <a class="drug drug_pediatric" data-topicid="12741" href="/d/drug information/12741.html" rel="external">propofol</a> is widely used by anesthesiologists as an induction agent for general anesthesia. It is also sometimes used by nonanesthesiologists (eg, emergency medicine specialists) for procedural sedation in children. (See  <a class="medical medical_review" href="/d/html/82857.html" rel="external">"Pediatric procedural sedation: Pharmacologic agents", section on 'Propofol'</a>.)</p><p><a class="drug drug_pediatric" data-topicid="12741" href="/d/drug information/12741.html" rel="external">Propofol</a> is used in some centers for elective endotracheal intubation in neonates [<a href="#rid20">20,161,162</a>], though it is not used for this purpose at the author's center. Otherwise, propofol is not commonly used for procedural sedation in neonates due to the unfavorable side effect profile in this population. It almost universally causes apnea, and it frequently causes hypotension and/or bradycardia [<a href="#rid163">163,164</a>]. </p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multimodal approach</strong> – A multimodal approach to neonatal pain management includes the following (see <a class="local">'Multimodal approach'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonpharmacologic measures (eg, skin-to-skin contact, breastfeeding, non-nutritive sucking, swaddling) – In some cases, these measures alone may be sufficient. (See <a class="local">'Nonpharmacologic measures'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Topical or local anesthetics. (See <a class="local">'Topical anesthetics'</a> above and <a class="local">'Local anesthesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Systemic analgesic medications. (See <a class="local">'Acetaminophen'</a> above and <a class="local">'Opioids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedural analgesia</strong> – The need for specific analgesic drug therapy depends on the degree of anticipated procedural pain  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>). (See <a class="local">'Procedural analgesia'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Simple procedures associated with mild pain</strong> – For neonates undergoing brief painful procedures  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>), we suggest oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> (or other sweet tasting liquid) in combination with nonpharmacologic measures rather than nonpharmacologic measures alone (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). We use weight-based dosing for sucrose and prescribe and track it as a medication. (See <a class="local">'Mildly painful (heel lance, venipuncture, etc)'</a> above and <a class="local">'Oral sucrose and other sweet liquids'</a> above and <a class="local">'Nonpharmacologic measures'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Simple procedures associated with moderate pain</strong> – For neonates undergoing procedures associated with moderate pain  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>), we suggest a topical anesthetic in addition to oral <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> and nonpharmacologic measures (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). If the neonate does not achieve adequate analgesia from these measures, a low dose of a short-acting opioid (eg, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) may be required. (See <a class="local">'Moderately painful (lumbar puncture, arterial puncture, etc)'</a> above and <a class="local">'Topical anesthetics'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>More complex procedures</strong> – For neonates undergoing more complex procedures associated with moderate pain and which require the neonate to remain still (eg, central venous catheter [CVC] placement, chest tube insertion)  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>), we suggest local anesthesia plus a short-acting sedative/analgesic (eg, <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, or <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) rather than other agents or combinations (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). These measures are used in addition to <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> and nonpharmacologic measures. (See <a class="local">'More complex procedures'</a> above and <a class="local">'Opioids'</a> above and <a class="local">'Ketamine'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sedation/analgesia for elective intubation</strong> – For neonates undergoing elective endotracheal intubation, we suggest premedication with <a class="drug drug_pediatric" data-topicid="13398" href="/d/drug information/13398.html" rel="external">ketamine</a> rather than other agents or drug combinations (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). A short-acting opioid (eg, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>) is a reasonable alternative. (See <a class="local">'Endotracheal intubation'</a> above and <a class="local">'Ketamine'</a> above and <a class="local">'Opioids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative pain</strong> – Postoperative pain management is tailored to the specific surgical procedure. For most neonates undergoing major surgery, we suggest regularly scheduled <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a> (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>) since it reduces the need for opioid therapy. Nonpharmacologic measures should also be used to reduce pain. Intermittent doses of an opioid (eg, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>) may be required depending on the specific surgical procedure. (See <a class="local">'Postoperative pain'</a> above and <a class="local">'Acetaminophen'</a> above and <a class="local">'Opioids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prolonged pain/discomfort</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sedation/analgesia for mechanical ventilation</strong> – For intubated neonates receiving ongoing mechanical ventilation, the typical sedation/analgesia regimen includes nonpharmacologic measures, as-needed <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a>, and intermittent doses of an opioid (eg, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>, <a class="drug drug_pediatric" data-topicid="12812" href="/d/drug information/12812.html" rel="external">sufentanil</a>). For patients receiving opioids, we suggest starting with intermittent dosing rather than a continuous opioid infusion or a combined opioid/benzodiazepine regimen (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). However, neonates with poorly controlled pain or severe agitation may require a continuous opioid infusion and/or the addition of a sedative agent (eg, <a class="drug drug_pediatric" data-topicid="12611" href="/d/drug information/12611.html" rel="external">midazolam</a> or <a class="drug drug_pediatric" data-topicid="13128" href="/d/drug information/13128.html" rel="external">dexmedetomidine</a>). (See <a class="local">'Mechanical ventilation'</a> above and <a class="local">'Opioids'</a> above and <a class="local">'Sedatives'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other painful conditions</strong> – Acutely ill neonates with conditions associated with moderate to severe pain (eg, necrotizing enterocolitis, meningitis, indwelling chest tube)  (<a class="graphic graphic_table graphicRef140134" href="/d/graphic/140134.html" rel="external">table 2</a>) may require intermittent doses of an opioid (eg, <a class="drug drug_pediatric" data-topicid="16024" href="/d/drug information/16024.html" rel="external">morphine</a>, <a class="drug drug_pediatric" data-topicid="13298" href="/d/drug information/13298.html" rel="external">fentanyl</a>) in addition to <a class="drug drug_pediatric" data-topicid="13028" href="/d/drug information/13028.html" rel="external">acetaminophen</a>, <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a>, and nonpharmacologic measures. (See <a class="local">'General approach'</a> above and <a class="local">'Opioids'</a> above and <a class="local">'Acetaminophen'</a> above.)</p><p></p><p class="headingAnchor" id="H1382743812"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Kanwaljeet Anand, MBBS, DPhil, FAAP, FCCM, FRCPCH, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">COMMITTEE ON FETUS AND NEWBORN and SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE. Prevention and Management of Procedural Pain in the Neonate: An Update. Pediatrics 2016; 137:e20154271.</a></li><li><a class="nounderline abstract_t">Sharek PJ, Powers R, Koehn A, Anand KJ. Evaluation and development of potentially better practices to improve pain management of neonates. Pediatrics 2006; 118 Suppl 2:S78.</a></li><li><a class="nounderline abstract_t">Bellieni CV, Buonocore G. Neonatal pain treatment: ethical to be effective. J Perinatol 2008; 28:87.</a></li><li><a class="nounderline abstract_t">Bellieni CV, Cordelli DM, Marchi S, et al. Sensorial saturation for neonatal analgesia. Clin J Pain 2007; 23:219.</a></li><li><a class="nounderline abstract_t">Chermont AG, Falcão LF, de Souza Silva EH, et al. Skin-to-skin contact and/or oral 25% dextrose for procedural pain relief for term newborn infants. Pediatrics 2009; 124:e1101.</a></li><li><a class="nounderline abstract_t">O'Sullivan A, O'Connor M, Brosnahan D, et al. Sweeten, soother and swaddle for retinopathy of prematurity screening: a randomised placebo controlled trial. Arch Dis Child Fetal Neonatal Ed 2010; 95:F419.</a></li><li><a class="nounderline abstract_t">Marín Gabriel MÁ, del Rey Hurtado de Mendoza B, Jiménez Figueroa L, et al. Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick. Arch Dis Child Fetal Neonatal Ed 2013; 98:F499.</a></li><li><a class="nounderline abstract_t">Taddio A, Lee C, Yip A, et al. Intravenous morphine and topical tetracaine for treatment of pain in [corrected] neonates undergoing central line placement. JAMA 2006; 295:793.</a></li><li><a class="nounderline abstract_t">Kinoshita M, Olsson E, Borys F, Bruschettini M. Opioids for procedural pain in neonates. Cochrane Database Syst Rev 2023; 6:CD015056.</a></li><li><a class="nounderline abstract_t">Sun X, Lemyre B, Barrowman N, O'Connor M. Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review. Acta Paediatr 2010; 99:329.</a></li><li><a class="nounderline abstract_t">Ahmed M, Forcina B, Bonsall D. Quantifying and qualifying the use of topical anesthetics in retinopathy of prematurity examinations. J AAPOS 2016; 20:177.</a></li><li><a class="nounderline abstract_t">Dempsey E, McCreery K. Local anaesthetic eye drops for prevention of pain in preterm infants undergoing screening for retinopathy of prematurity. Cochrane Database Syst Rev 2011; :CD007645.</a></li><li><a class="nounderline abstract_t">Olsson E, Eriksson M. Oral glucose for pain relief during eye examinations for retinopathy of prematurity. J Clin Nurs 2011; 20:1054.</a></li><li><a class="nounderline abstract_t">Rush R, Rush S, Ighani F, et al. The effects of comfort care on the pain response in preterm infants undergoing screening for retinopathy of prematurity. Retina 2005; 25:59.</a></li><li><a class="nounderline abstract_t">Costa MC, Eckert GU, Fortes BG, et al. Oral glucose for pain relief during examination for retinopathy of prematurity: a masked randomized clinical trial. Clinics (Sao Paulo) 2013; 68:199.</a></li><li><a class="nounderline abstract_t">Wang DN, Lavery K, Dalgleish S, et al. Reducing discomfort of eye drops prior to retinal examination in the neonatal intensive care unit. J Perinatol 2020; 40:1857.</a></li><li><a class="nounderline abstract_t">Sindhur M, Balasubramanian H, Srinivasan L, et al. Intranasal fentanyl for pain management during screening for retinopathy of prematurity in preterm infants: a randomized controlled trial. J Perinatol 2020; 40:881.</a></li><li><a class="nounderline abstract_t">Pereira e Silva Y, Gomez RS, Marcatto Jde O, et al. Morphine versus remifentanil for intubating preterm neonates. Arch Dis Child Fetal Neonatal Ed 2007; 92:F293.</a></li><li><a class="nounderline abstract_t">Roberts KD, Leone TA, Edwards WH, et al. Premedication for nonemergent neonatal intubations: a randomized, controlled trial comparing atropine and fentanyl to atropine, fentanyl, and mivacurium. Pediatrics 2006; 118:1583.</a></li><li><a class="nounderline abstract_t">Walter-Nicolet E, Marchand-Martin L, Guellec I, et al. Premedication practices for neonatal tracheal intubation: Results from the EPIPPAIN 2 prospective cohort study and comparison with EPIPPAIN 1. Paediatr Neonatal Pain 2021; 3:46.</a></li><li><a class="nounderline abstract_t">Avino D, Zhang WH, De Villé A, Johansson AB. Remifentanil versus morphine-midazolam premedication on the quality of endotracheal intubation in neonates: a noninferiority randomized trial. J Pediatr 2014; 164:1032.</a></li><li><a class="nounderline abstract_t">Attardi DM, Paul DA, Tuttle DJ, Greenspan JS. Premedication for intubation in neonates. Arch Dis Child Fetal Neonatal Ed 2000; 83:F161.</a></li><li><a class="nounderline abstract_t">Barois J, Tourneux P. Ketamine and atropine decrease pain for preterm newborn tracheal intubation in the delivery room: an observational pilot study. Acta Paediatr 2013; 102:e534.</a></li><li><a class="nounderline abstract_t">Bouwmeester NJ, Hop WC, van Dijk M, et al. Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism. Intensive Care Med 2003; 29:2009.</a></li><li><a class="nounderline abstract_t">van Dijk M, Bouwmeester NJ, Duivenvoorden HJ, et al. Efficacy of continuous versus intermittent morphine administration after major surgery in 0-3-year-old infants; a double-blind randomized controlled trial. Pain 2002; 98:305.</a></li><li><a class="nounderline abstract_t">Kinoshita M, Borges do Nascimento IJ, Styrmisdóttir L, Bruschettini M. Systemic opioid regimens for postoperative pain in neonates. Cochrane Database Syst Rev 2023; 4:CD015016.</a></li><li><a class="nounderline abstract_t">El Sayed MF, Taddio A, Fallah S, et al. Safety profile of morphine following surgery in neonates. J Perinatol 2007; 27:444.</a></li><li><a class="nounderline abstract_t">van Ganzewinkel CJ, Anand KJ, Kramer BW, Andriessen P. Chronic pain in the newborn: toward a definition. Clin J Pain 2014; 30:970.</a></li><li><a class="nounderline abstract_t">Pillai Riddell RR, Stevens BJ, McKeever P, et al. Chronic pain in hospitalized infants: health professionals' perspectives. J Pain 2009; 10:1217.</a></li><li><a class="nounderline abstract_t">DiLorenzo M, Pillai Riddell R, Holsti L. Beyond Acute Pain: Understanding Chronic Pain in Infancy. Children (Basel) 2016; 3.</a></li><li><a class="nounderline abstract_t">Allegaert K, Naulaers G. Gabapentin as part of multimodal analgesia in a newborn with epidermolysis bullosa. Paediatr Anaesth 2010; 20:972.</a></li><li><a class="nounderline abstract_t">Hummel P, Puchalski M, Creech SD, Weiss MG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J Perinatol 2008; 28:55.</a></li><li><a class="nounderline abstract_t">Deindl P, Unterasinger L, Kappler G, et al. Successful implementation of a neonatal pain and sedation protocol at 2 NICUs. Pediatrics 2013; 132:e211.</a></li><li><a class="nounderline abstract_t">Deindl P, Giordano V, Fuiko R, et al. The implementation of systematic pain and sedation management has no impact on outcome in extremely preterm infants. Acta Paediatr 2016; 105:798.</a></li><li><a class="nounderline abstract_t">Carbajal R, Eriksson M, Courtois E, et al. Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study. Lancet Respir Med 2015; 3:796.</a></li><li><a class="nounderline abstract_t">Simons SH, van Dijk M, van Lingen RA, et al. Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA 2003; 290:2419.</a></li><li><a class="nounderline abstract_t">Bellù R, Romantsik O, Nava C, et al. Opioids for newborn infants receiving mechanical ventilation. Cochrane Database Syst Rev 2021; 3:CD013732.</a></li><li><a class="nounderline abstract_t">Anand KJ, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 2004; 363:1673.</a></li><li><a class="nounderline abstract_t">Ancora G, Lago P, Garetti E, et al. Efficacy and safety of continuous infusion of fentanyl for pain control in preterm newborns on mechanical ventilation. J Pediatr 2013; 163:645.</a></li><li><a class="nounderline abstract_t">de Tristan MA, Martin-Marchand L, Roué JM, et al. Association of Continuous Opioids and/or Midazolam During Early Mechanical Ventilation with Survival and Sensorimotor Outcomes at Age 2 Years in Premature Infants: Results from the French Prospective National EPIPAGE 2 Cohort. J Pediatr 2021; 232:38.</a></li><li><a class="nounderline abstract_t">O'Mara K, Weiss MD. Dexmedetomidine for Sedation of Neonates with HIE Undergoing Therapeutic Hypothermia: A Single-Center Experience. AJP Rep 2018; 8:e168.</a></li><li><a class="nounderline abstract_t">Naveed M, Bondi DS, Shah PA. Dexmedetomidine Versus Fentanyl for Neonates With Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia. J Pediatr Pharmacol Ther 2022; 27:352.</a></li><li><a class="nounderline abstract_t">Elliott M, Burnsed J, Heinan K, et al. Effect of dexmedetomidine on heart rate in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia. J Neonatal Perinatal Med 2022; 15:47.</a></li><li><a class="nounderline abstract_t">Favié LMA, Groenendaal F, van den Broek MPH, et al. Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia. PLoS One 2019; 14:e0211910.</a></li><li><a class="nounderline abstract_t">Róka A, Melinda KT, Vásárhelyi B, et al. Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics 2008; 121:e844.</a></li><li><a class="nounderline abstract_t">Bäcke P, Bruschettini M, Sibrecht G, et al. Pharmacological interventions for pain and sedation management in newborn infants undergoing therapeutic hypothermia. Cochrane Database Syst Rev 2022; 11:CD015023.</a></li><li><a class="nounderline abstract_t">Angeles DM, Wycliffe N, Michelson D, et al. Use of opioids in asphyxiated term neonates: effects on neuroimaging and clinical outcome. Pediatr Res 2005; 57:873.</a></li><li><a class="nounderline abstract_t">Liow N, Montaldo P, Lally PJ, et al. Preemptive Morphine During Therapeutic Hypothermia After Neonatal Encephalopathy: A Secondary Analysis. Ther Hypothermia Temp Manag 2020; 10:45.</a></li><li><a class="nounderline abstract_t">Nakhleh-Philippe P, Zores C, Stern-Delfils A, et al. Adequacy of sedation analgesia to support the comfort of neonates undergoing therapeutic hypothermia and its impact on short-term neonatal outcomes. Front Pediatr 2023; 11:1057724.</a></li><li><a class="nounderline abstract_t">Bäcke P, Bruschettini M, Blomqvist YT, et al. Interventions for the Management of Pain and Sedation in Newborns Undergoing Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy: A Systematic Review. Paediatr Drugs 2023; 25:27.</a></li><li><a class="nounderline abstract_t">Baserga M, DuPont TL, Ostrander B, et al. Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial): A Randomized Controlled Trial: Background, Aims and Study Protocol. Front Pain Res (Lausanne) 2021; 2:770511.</a></li><li><a class="nounderline abstract_t">Zimmerman KO, Hornik CP, Ku L, et al. Sedatives and Analgesics Given to Infants in Neonatal Intensive Care Units at the End of Life. J Pediatr 2015; 167:299.</a></li><li><a class="nounderline abstract_t">Pillai Riddell RR, Bucsea O, Shiff I, et al. Non-pharmacological management of infant and young child procedural pain. Cochrane Database Syst Rev 2023; 6:CD006275.</a></li><li><a class="nounderline abstract_t">Shah PS, Herbozo C, Aliwalas LL, Shah VS. Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database Syst Rev 2012; 12:CD004950.</a></li><li><a class="nounderline abstract_t">Weissman A, Aranovitch M, Blazer S, Zimmer EZ. Heel-lancing in newborns: behavioral and spectral analysis assessment of pain control methods. Pediatrics 2009; 124:e921.</a></li><li><a class="nounderline abstract_t">Benoit B, Martin-Misener R, Latimer M, Campbell-Yeo M. Breast-Feeding Analgesia in Infants: An Update on the Current State of Evidence. J Perinat Neonatal Nurs 2017; 31:145.</a></li><li><a class="nounderline abstract_t">Brovedani P, Montico M, Shardlow A, et al. Suckling and sugar for pain reduction in babies. Lancet 2007; 369:1429.</a></li><li><a class="nounderline abstract_t">Gomes Neto M, da Silva Lopes IA, Araujo ACCLM, et al. The effect of facilitated tucking position during painful procedure in pain management of preterm infants in neonatal intensive care unit: a systematic review and meta-analysis. Eur J Pediatr 2020; 179:699.</a></li><li><a class="nounderline abstract_t">Cignacco EL, Sellam G, Stoffel L, et al. Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial. Pediatrics 2012; 129:299.</a></li><li><a class="nounderline abstract_t">Johnston CC, Stevens B, Pinelli J, et al. Kangaroo care is effective in diminishing pain response in preterm neonates. Arch Pediatr Adolesc Med 2003; 157:1084.</a></li><li><a class="nounderline abstract_t">Ludington-Hoe SM, Hosseini R, Torowicz DL. Skin-to-skin contact (Kangaroo Care) analgesia for preterm infant heel stick. AACN Clin Issues 2005; 16:373.</a></li><li><a class="nounderline abstract_t">Freire NB, Garcia JB, Lamy ZC. Evaluation of analgesic effect of skin-to-skin contact compared to oral glucose in preterm neonates. Pain 2008; 139:28.</a></li><li><a class="nounderline abstract_t">Johnston C, Campbell-Yeo M, Disher T, et al. Skin-to-skin care for procedural pain in neonates. Cochrane Database Syst Rev 2017; 2:CD008435.</a></li><li><a class="nounderline abstract_t">Bellieni CV, Bagnoli F, Perrone S, et al. Effect of multisensory stimulation on analgesia in term neonates: a randomized controlled trial. Pediatr Res 2002; 51:460.</a></li><li><a class="nounderline abstract_t">Bellieni CV, Buonocore G, Nenci A, et al. Sensorial saturation: an effective analgesic tool for heel-prick in preterm infants: a prospective randomized trial. Biol Neonate 2001; 80:15.</a></li><li><a class="nounderline abstract_t">Gray L, Garza E, Zageris D, et al. Sucrose and warmth for analgesia in healthy newborns: an RCT. Pediatrics 2015; 135:e607.</a></li><li><a class="nounderline abstract_t">Hartling L, Shaik MS, Tjosvold L, et al. Music for medical indications in the neonatal period: a systematic review of randomised controlled trials. Arch Dis Child Fetal Neonatal Ed 2009; 94:F349.</a></li><li><a class="nounderline abstract_t">Shah SR, Kadage S, Sinn J. Trial of Music, Sucrose, and Combination Therapy for Pain Relief during Heel Prick Procedures in Neonates. J Pediatr 2017; 190:153.</a></li><li><a class="nounderline abstract_t">Chik YM, Ip WY, Choi KC. The Effect of Upper Limb Massage on Infants' Venipuncture Pain. Pain Manag Nurs 2017; 18:50.</a></li><li><a class="nounderline abstract_t">Jain S, Kumar P, McMillan DD. Prior leg massage decreases pain responses to heel stick in preterm babies. J Paediatr Child Health 2006; 42:505.</a></li><li><a class="nounderline abstract_t">Niemi AK. Review of Randomized Controlled Trials of Massage in Preterm Infants. Children (Basel) 2017; 4.</a></li><li><a class="nounderline abstract_t">Juneau AL, Aita M, Héon M. Review and Critical Analysis of Massage Studies for Term and Preterm Infants. Neonatal Netw 2015; 34:165.</a></li><li><a class="nounderline abstract_t">Fitri SYR, Nasution SK, Nurhidayah I, Maryam NNA. Massage therapy as a non-pharmacological analgesia for procedural pain in neonates: A scoping review. Complement Ther Med 2021; 59:102735.</a></li><li><a class="nounderline abstract_t">Livingston K, Beider S, Kant AJ, et al. Touch and massage for medically fragile infants. Evid Based Complement Alternat Med 2009; 6:473.</a></li><li><a class="nounderline abstract_t">Ramada NC, Almeida Fde A, Cunha ML. Therapeutic touch: influence on vital signs of newborns. Einstein (Sao Paulo) 2013; 11:421.</a></li><li><a class="nounderline abstract_t">Johnston C, Campbell-Yeo M, Rich B, et al. Therapeutic touch is not therapeutic for procedural pain in very preterm neonates: a randomized trial. Clin J Pain 2013; 29:824.</a></li><li><a class="nounderline abstract_t">Cerritelli F, Cicchitti L, Martelli M, et al. Osteopathic manipulative treatment and pain in preterms: study protocol for a randomised controlled trial. Trials 2015; 16:84.</a></li><li><a class="nounderline abstract_t">Mitchell AJ, Hall RW, Golianu B, et al. Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates? Acta Paediatr 2016; 105:1434.</a></li><li><a class="nounderline abstract_t">Abbasoğlu A, Cabıoğlu MT, Tuğcu AU, et al. Acupressure at BL60 and K3 Points Before Heel Lancing in Preterm Infants. Explore (NY) 2015; 11:363.</a></li><li><a class="nounderline abstract_t">Abbasoglu A, Cabioglu MT, Tugcu AU, et al. Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial. Acupunct Med 2015; 33:445.</a></li><li><a class="nounderline abstract_t">Stevens B, Yamada J, Ohlsson A, et al. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev 2016; 7:CD001069.</a></li><li><a class="nounderline abstract_t">Harrison D, Larocque C, Bueno M, et al. Sweet Solutions to Reduce Procedural Pain in Neonates: A Meta-analysis. Pediatrics 2017; 139.</a></li><li><a class="nounderline abstract_t">Bueno M, Yamada J, Harrison D, et al. A systematic review and meta-analyses of nonsucrose sweet solutions for pain relief in neonates. Pain Res Manag 2013; 18:153.</a></li><li><a class="nounderline abstract_t">Blass EM, Shah A. Pain-reducing properties of sucrose in human newborns. Chem Senses 1995; 20:29.</a></li><li><a class="nounderline abstract_t">Johnston CC, Stremler R, Horton L, Friedman A. Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biol Neonate 1999; 75:160.</a></li><li><a class="nounderline abstract_t">Johnston CC, Filion F, Snider L, et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. Pediatrics 2002; 110:523.</a></li><li><a class="nounderline abstract_t">Thakkar P, Arora K, Goyal K, et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. J Perinatol 2016; 36:67.</a></li><li><a class="nounderline abstract_t">Meesters N, Simons S, van Rosmalen J, et al. Waiting 2 minutes after sucrose administration-unnecessary? Arch Dis Child Fetal Neonatal Ed 2017; 102:F167.</a></li><li><a class="nounderline abstract_t">Stevens B, Yamada J, Beyene J, et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: Is it effective and safe for repeated use over time? Clin J Pain 2005; 21:543.</a></li><li><a class="nounderline abstract_t">Lago P, Cavicchiolo ME, Mion T, et al. Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial. Eur J Pediatr 2020; 179:293.</a></li><li><a class="nounderline abstract_t">Gao H, Gao H, Xu G, et al. Efficacy and safety of repeated oral sucrose for repeated procedural pain in neonates: A systematic review. Int J Nurs Stud 2016; 62:118.</a></li><li><a class="nounderline abstract_t">Holsti L, Grunau RE. Considerations for using sucrose to reduce procedural pain in preterm infants. Pediatrics 2010; 125:1042.</a></li><li><a class="nounderline abstract_t">Taddio A, Shah V, Hancock R, et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. CMAJ 2008; 179:37.</a></li><li><a class="nounderline abstract_t">Gradin M, Schollin J. The role of endogenous opioids in mediating pain reduction by orally administered glucose among newborns. Pediatrics 2005; 115:1004.</a></li><li><a class="nounderline abstract_t">Taddio A, Shah V, Shah P, Katz J. Beta-endorphin concentration after administration of sucrose in preterm infants. Arch Pediatr Adolesc Med 2003; 157:1071.</a></li><li><a class="nounderline abstract_t">Foster JP, Taylor C, Spence K. Topical anaesthesia for needle-related pain in newborn infants. Cochrane Database Syst Rev 2017; 2:CD010331.</a></li><li><a class="nounderline abstract_t">Weise KL, Nahata MC. EMLA for painful procedures in infants. J Pediatr Health Care 2005; 19:42.</a></li><li><a class="nounderline abstract_t">Taddio A, Shennan AT, Stevens B, et al. Safety of lidocaine-prilocaine cream in the treatment of preterm neonates. J Pediatr 1995; 127:1002.</a></li><li><a class="nounderline abstract_t">Maulidi H, McNair C, Seller N, et al. Arrhythmia associated with tetracaine in an extremely low birth weight premature infant. Pediatrics 2012; 130:e1704.</a></li><li><a class="nounderline abstract_t">O'Brien L, Taddio A, Lyszkiewicz DA, Koren G. A critical review of the topical local anesthetic amethocaine (Ametop) for pediatric pain. Paediatr Drugs 2005; 7:41.</a></li><li><a class="nounderline abstract_t">Browne J, Awad I, Plant R, et al. Topical amethocaine (Ametop) is superior to EMLA for intravenous cannulation. Eutectic mixture of local anesthetics. Can J Anaesth 1999; 46:1014.</a></li><li><a class="nounderline abstract_t">Shahid S, Florez ID, Mbuagbaw L. Efficacy and Safety of EMLA Cream for Pain Control Due to Venipuncture in Infants: A Meta-analysis. Pediatrics 2019; 143.</a></li><li><a class="nounderline abstract_t">Biran V, Gourrier E, Cimerman P, et al. Analgesic effects of EMLA cream and oral sucrose during venipuncture in preterm infants. Pediatrics 2011; 128:e63.</a></li><li><a class="nounderline abstract_t">Ferayorni A, Yniguez R, Bryson M, Bulloch B. Needle-free jet injection of lidocaine for local anesthesia during lumbar puncture: a randomized controlled trial. Pediatr Emerg Care 2012; 28:687.</a></li><li><a class="nounderline abstract_t">Howard CR, Howard FM, Weitzman ML. Acetaminophen analgesia in neonatal circumcision: the effect on pain. Pediatrics 1994; 93:641.</a></li><li><a class="nounderline abstract_t">Shah V, Taddio A, Ohlsson A. Randomised controlled trial of paracetamol for heel prick pain in neonates. Arch Dis Child Fetal Neonatal Ed 1998; 79:F209.</a></li><li><a class="nounderline abstract_t">Ohlsson A, Shah PS. Paracetamol (acetaminophen) for prevention or treatment of pain in newborns. Cochrane Database Syst Rev 2020; 1:CD011219.</a></li><li><a class="nounderline abstract_t">Roofthooft DWE, Simons SHP, van Lingen RA, et al. Randomized Controlled Trial Comparing Different Single Doses of Intravenous Paracetamol for Placement of Peripherally Inserted Central Catheters in Preterm Infants. Neonatology 2017; 112:150.</a></li><li><a class="nounderline abstract_t">Rana D, Bellflower B, Sahni J, et al. Reduced narcotic and sedative utilization in a NICU after implementation of pain management guidelines. J Perinatol 2017; 37:1038.</a></li><li><a class="nounderline abstract_t">Allegaert K, van den Anker JN. Perinatal and neonatal use of paracetamol for pain relief. Semin Fetal Neonatal Med 2017; 22:308.</a></li><li><a class="nounderline abstract_t">Anderson BJ, van Lingen RA, Hansen TG, et al. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 2002; 96:1336.</a></li><li><a class="nounderline abstract_t">van Lingen RA, Deinum HT, Quak CM, et al. Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants. Clin Pharmacol Ther 1999; 66:509.</a></li><li><a class="nounderline abstract_t">van Lingen RA, Deinum JT, Quak JM, et al. Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80:F59.</a></li><li><a class="nounderline abstract_t">Anderson BJ, Pons G, Autret-Leca E, et al. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth 2005; 15:282.</a></li><li><a class="nounderline abstract_t">Arana A, Morton NS, Hansen TG. Treatment with paracetamol in infants. Acta Anaesthesiol Scand 2001; 45:20.</a></li><li><a class="nounderline abstract_t">Anderson BJ, Woollard GA, Holford NH. A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 2000; 50:125.</a></li><li><a class="nounderline abstract_t">Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child 2011; 96:575.</a></li><li><a class="nounderline abstract_t">Veyckemans F, Anderson BJ, Wolf AR, Allegaert K. Intravenous paracetamol dosage in the neonate and small infant. Br J Anaesth 2014; 112:380.</a></li><li><a class="nounderline abstract_t">van der Marel CD, Peters JW, Bouwmeester NJ, et al. Rectal acetaminophen does not reduce morphine consumption after major surgery in young infants. Br J Anaesth 2007; 98:372.</a></li><li><a class="nounderline abstract_t">Allegaert K, Naulaers G, Vanhaesebrouck S, Anderson BJ. The paracetamol concentration-effect relation in neonates. Paediatr Anaesth 2013; 23:45.</a></li><li><a class="nounderline abstract_t">Cuzzolin L, Antonucci R, Fanos V. Paracetamol (acetaminophen) efficacy and safety in the newborn. Curr Drug Metab 2013; 14:178.</a></li><li><a class="nounderline abstract_t">Ceelie I, de Wildt SN, van Dijk M, et al. Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. JAMA 2013; 309:149.</a></li><li><a class="nounderline abstract_t">Härmä A, Aikio O, Hallman M, Saarela T. Intravenous Paracetamol Decreases Requirements of Morphine in Very Preterm Infants. J Pediatr 2016; 168:36.</a></li><li><a class="nounderline abstract_t">Baarslag MA, Ista E, de Leeuw T, et al. Clinically effective implementation of intravenous paracetamol as primary analgesia after major surgery in neonates and young infants. Arch Dis Child 2018; 103:1168.</a></li><li><a class="nounderline abstract_t">Grabski DF, Vavolizza RD, Lepore S, et al. A Quality Improvement Intervention to Reduce Postoperative Opiate Use in Neonates. Pediatrics 2020; 146.</a></li><li><a class="nounderline abstract_t">Truog R, Anand KJ. Management of pain in the postoperative neonate. Clin Perinatol 1989; 16:61.</a></li><li><a class="nounderline abstract_t">Anderson BJ, Holford NH, Armishaw JC, Aicken R. Predicting concentrations in children presenting with acetaminophen overdose. J Pediatr 1999; 135:290.</a></li><li><a class="nounderline abstract_t">Hopchet L, Kulo A, Rayyan M, et al. Does intravenous paracetamol administration affect body temperature in neonates? Arch Dis Child 2011; 96:301.</a></li><li><a class="nounderline abstract_t">Juujärvi S, Saarela T, Pokka T, et al. Intravenous paracetamol for neonates: long-term diseases not escalated during 5 years of follow-up. Arch Dis Child Fetal Neonatal Ed 2021; 106:178.</a></li><li><a class="nounderline abstract_t">Zenker M, Klinge J, Krüger C, et al. Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 1998; 26:231.</a></li><li><a class="nounderline abstract_t">Aldrink JH, Ma M, Wang W, et al. Safety of ketorolac in surgical neonates and infants 0 to 3 months old. J Pediatr Surg 2011; 46:1081.</a></li><li><a class="nounderline abstract_t">Hartley C, Moultrie F, Hoskin A, et al. Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial. Lancet 2018; 392:2595.</a></li><li><a class="nounderline abstract_t">Fleishman R, Zhou C, Gleason C, et al. Standardizing morphine use for ventilated preterm neonates with a nursing-driven comfort protocol. J Perinatol 2015; 35:46.</a></li><li><a class="nounderline abstract_t">Czarnecki ML, Hainsworth K, Simpson PM, et al. Is there an alternative to continuous opioid infusion for neonatal pain control? A preliminary report of parent/nurse-controlled analgesia in the neonatal intensive care unit. Paediatr Anaesth 2014; 24:377.</a></li><li><a class="nounderline abstract_t">Czarnecki ML, Hainsworth K, Simpson PM, et al. A Pilot Randomized Controlled Trial of Outcomes Associated with Parent-Nurse Controlled Analgesia vs. Continuous Opioid Infusion in the Neonatal Intensive Care Unit. Pain Manag Nurs 2020; 21:72.</a></li><li><a class="nounderline abstract_t">Schmidt B, Adelmann C, Stützer H, et al. Comparison of sufentanil versus fentanyl in ventilated term neonates. Klin Padiatr 2010; 222:62.</a></li><li><a class="nounderline abstract_t">Saarenmaa E, Huttunen P, Leppäluoto J, et al. Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: A randomized trial. J Pediatr 1999; 134:144.</a></li><li><a class="nounderline abstract_t">Örge FH, Lee TJ, Walsh M, Gordon K. Comparison of fentanyl and morphine in laser surgery for retinopathy of prematurity. J AAPOS 2013; 17:135.</a></li><li><a class="nounderline abstract_t">Franck LS, Vilardi J, Durand D, Powers R. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care 1998; 7:364.</a></li><li><a class="nounderline abstract_t">Anand KJ, Willson DF, Berger J, et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics 2010; 125:e1208.</a></li><li><a class="nounderline abstract_t">Hall RW, Kronsberg SS, Barton BA, et al. Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial. Pediatrics 2005; 115:1351.</a></li><li><a class="nounderline abstract_t">Dewhirst E, Naguib A, Tobias JD. Chest wall rigidity in two infants after low-dose fentanyl administration. Pediatr Emerg Care 2012; 28:465.</a></li><li><a class="nounderline abstract_t">Anand KJ, Barton BA, McIntosh N, et al. Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates. Arch Pediatr Adolesc Med 1999; 153:331.</a></li><li><a class="nounderline abstract_t">Arya V, Ramji S. Midazolam sedation in mechanically ventilated newborns: a double blind randomized placebo controlled trial. Indian Pediatr 2001; 38:967.</a></li><li><a class="nounderline abstract_t">Jacqz-Aigrain E, Daoud P, Burtin P, et al. Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies. Lancet 1994; 344:646.</a></li><li><a class="nounderline abstract_t">Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Rev 2017; 1:CD002052.</a></li><li><a class="nounderline abstract_t">Stevens MF, Werdehausen R, Gaza N, et al. Midazolam activates the intrinsic pathway of apoptosis independent of benzodiazepine and death receptor signaling. Reg Anesth Pain Med 2011; 36:343.</a></li><li><a class="nounderline abstract_t">Hall RW, Shbarou RM. Drugs of choice for sedation and analgesia in the neonatal ICU. Clin Perinatol 2009; 36:215.</a></li><li><a class="nounderline abstract_t">Bétrémieux P, Carré P, Pladys P, et al. Doppler ultrasound assessment of the effects of ketamine on neonatal cerebral circulation. Dev Pharmacol Ther 1993; 20:9.</a></li><li><a class="nounderline abstract_t">Saarenmaa E, Neuvonen PJ, Huttunen P, Fellman V. Ketamine for procedural pain relief in newborn infants. Arch Dis Child Fetal Neonatal Ed 2001; 85:F53.</a></li><li><a class="nounderline abstract_t">D'Andrea V, Prontera G, Barone G, Vento G. Combination of ketamine and fentanyl (KetaFent) for safe insertion of ultrasound-guided central venous catheters in infants. Front Pediatr 2023; 11:1033793.</a></li><li><a class="nounderline abstract_t">Madathil S, Thomas D, Chandra P, et al. 'NOPAIN-ROP' trial: Intravenous fentanyl and intravenous ketamine for pain relief during laser photocoagulation for retinopathy of prematurity (ROP) in preterm infants: A randomised trial. BMJ Open 2021; 11:e046235.</a></li><li><a class="nounderline abstract_t">Persad E, Pizarro AB, Bruschettini M. Non-opioid analgesics for procedural pain in neonates. Cochrane Database Syst Rev 2023; 4:CD015179.</a></li><li><a class="nounderline abstract_t">Finkel JC, Quezado ZM. Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J Clin Anesth 2007; 19:290.</a></li><li><a class="nounderline abstract_t">Berkenbosch JW, Tobias JD. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 2003; 4:203.</a></li><li><a class="nounderline abstract_t">Guillen-Hernandez J, Kyllonen KC, Tumin D, Rodriguez RJ. The Use of Dexmedetomidine in Preterm Infants: A Single Academic Center Experience. J Pediatr Pharmacol Ther 2023; 28:628.</a></li><li><a class="nounderline abstract_t">Smith HAB, Besunder JB, Betters KA, et al. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatr Crit Care Med 2022; 23:e74.</a></li><li><a class="nounderline abstract_t">Portelli K, Kandraju H, Ryu M, Shah PS. Efficacy and safety of dexmedetomidine for analgesia and sedation in neonates: a systematic review. J Perinatol 2023.</a></li><li><a class="nounderline abstract_t">Chrysostomou C, Schulman SR, Herrera Castellanos M, et al. A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr 2014; 164:276.</a></li><li><a class="nounderline abstract_t">Curtis S, Kilpatrick R, Billimoria ZC, et al. Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants. JAMA Netw Open 2023; 6:e2341033.</a></li><li><a class="nounderline abstract_t">Ghanta S, Abdel-Latif ME, Lui K, et al. Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial. Pediatrics 2007; 119:e1248.</a></li><li><a class="nounderline abstract_t">Simons SH, van der Lee R, Reiss IK, van Weissenbruch MM. Clinical evaluation of propofol as sedative for endotracheal intubation in neonates. Acta Paediatr 2013; 102:e487.</a></li><li><a class="nounderline abstract_t">de Kort EHM, Twisk JWR, van T Verlaat EPG, et al. Propofol in neonates causes a dose-dependent profound and protracted decrease in blood pressure. Acta Paediatr 2020; 109:2539.</a></li><li><a class="nounderline abstract_t">Welzing L, Kribs A, Eifinger F, et al. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates. Paediatr Anaesth 2010; 20:605.</a></li></ol></div><div id="topicVersionRevision">Topic 5018 Version 68.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26810788" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Prevention and Management of Procedural Pain in the Neonate: An Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17079627" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Evaluation and development of potentially better practices to improve pain management of neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18235507" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Neonatal pain treatment: ethical to be effective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17314580" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sensorial saturation for neonatal analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19948613" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Skin-to-skin contact and/or oral 25% dextrose for procedural pain relief for term newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20876596" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Sweeten, soother and swaddle for retinopathy of prematurity screening: a randomised placebo controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23839984" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16478902" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Intravenous morphine and topical tetracaine for treatment of pain in [corrected] neonates undergoing central line placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37350685" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Opioids for procedural pain in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19958293" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26994502" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Quantifying and qualifying the use of topical anesthetics in retinopathy of prematurity examinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21901708" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Local anaesthetic eye drops for prevention of pain in preterm infants undergoing screening for retinopathy of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21309874" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Oral glucose for pain relief during eye examinations for retinopathy of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15655442" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The effects of comfort care on the pain response in preterm infants undergoing screening for retinopathy of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23525316" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Oral glucose for pain relief during examination for retinopathy of prematurity: a masked randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33060779" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Reducing discomfort of eye drops prior to retinal examination in the neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32054982" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Intranasal fentanyl for pain management during screening for retinopathy of prematurity in preterm infants: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17074784" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Morphine versus remifentanil for intubating preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17015550" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Premedication for nonemergent neonatal intubations: a randomized, controlled trial comparing atropine and fentanyl to atropine, fentanyl, and mivacurium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35547594" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Premedication practices for neonatal tracheal intubation: Results from the EPIPPAIN 2 prospective cohort study and comparison with EPIPPAIN 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24582007" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Remifentanil versus morphine-midazolam premedication on the quality of endotracheal intubation in neonates: a noninferiority randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11012274" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Premedication for intubation in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24015945" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Ketamine and atropine decrease pain for preterm newborn tracheal intubation in the delivery room: an observational pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12897995" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12127032" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Efficacy of continuous versus intermittent morphine administration after major surgery in 0-3-year-old infants; a double-blind randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37018131" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Systemic opioid regimens for postoperative pain in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17592487" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Safety profile of morphine following surgery in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24296909" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Chronic pain in the newborn: toward a definition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19541547" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Chronic pain in hospitalized infants: health professionals' perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27834860" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Beyond Acute Pain: Understanding Chronic Pain in Infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20849513" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Gabapentin as part of multimodal analgesia in a newborn with epidermolysis bullosa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18165830" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23733799" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Successful implementation of a neonatal pain and sedation protocol at 2 NICUs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26792117" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The implementation of systematic pain and sedation management has no impact on outcome in extremely preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26420017" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14612478" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33729556" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Opioids for newborn infants receiving mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15158628" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23582138" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Efficacy and safety of continuous infusion of fentanyl for pain control in preterm newborns on mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33395567" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Association of Continuous Opioids and/or Midazolam During Early Mechanical Ventilation with Survival and Sensorimotor Outcomes at Age 2 Years in Premature Infants: Results from the French Prospective National EPIPAGE 2 Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30186671" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Dexmedetomidine for Sedation of Neonates with HIE Undergoing Therapeutic Hypothermia: A Single-Center Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35558346" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Dexmedetomidine Versus Fentanyl for Neonates With Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34334427" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Effect of dexmedetomidine on heart rate in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30763356" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18381513" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36354070" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pharmacological interventions for pain and sedation management in newborn infants undergoing therapeutic hypothermia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15774841" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Use of opioids in asphyxiated term neonates: effects on neuroimaging and clinical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30807267" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Preemptive Morphine During Therapeutic Hypothermia After Neonatal Encephalopathy: A Secondary Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36969279" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Adequacy of sedation analgesia to support the comfort of neonates undergoing therapeutic hypothermia and its impact on short-term neonatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36481984" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Interventions for the Management of Pain and Sedation in Newborns Undergoing Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35295519" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial): A Randomized Controlled Trial: Background, Aims and Study Protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26012893" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Sedatives and Analgesics Given to Infants in Neonatal Intensive Care Units at the End of Life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37314064" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Non-pharmacological management of infant and young child procedural pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23235618" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Breastfeeding or breast milk for procedural pain in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19841119" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Heel-lancing in newborns: behavioral and spectral analysis assessment of pain control methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28437305" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Breast-Feeding Analgesia in Infants: An Update on the Current State of Evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17467510" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Suckling and sugar for pain reduction in babies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32222816" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The effect of facilitated tucking position during painful procedure in pain management of preterm infants in neonatal intensive care unit: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22232305" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Oral sucrose and "facilitated tucking" for repeated pain relief in preterms: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14609899" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Kangaroo care is effective in diminishing pain response in preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16082239" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Skin-to-skin contact (Kangaroo Care) analgesia for preterm infant heel stick.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18434021" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Evaluation of analgesic effect of skin-to-skin contact compared to oral glucose in preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28205208" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Skin-to-skin care for procedural pain in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11919330" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effect of multisensory stimulation on analgesia in term neonates: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11474143" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Sensorial saturation: an effective analgesic tool for heel-prick in preterm infants: a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25687147" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Sucrose and warmth for analgesia in healthy newborns: an RCT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19477913" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Music for medical indications in the neonatal period: a systematic review of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29144240" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Trial of Music, Sucrose, and Combination Therapy for Pain Relief during Heel Prick Procedures in Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27964912" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The Effect of Upper Limb Massage on Infants' Venipuncture Pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16925535" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Prior leg massage decreases pain responses to heel stick in preterm babies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28368368" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Review of Randomized Controlled Trials of Massage in Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26802392" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Review and Critical Analysis of Massage Studies for Term and Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33974990" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Massage therapy as a non-pharmacological analgesia for procedural pain in neonates: A scoping review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18955228" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Touch and massage for medically fragile infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24488378" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Therapeutic touch: influence on vital signs of newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23817594" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Therapeutic touch is not therapeutic for procedural pain in very preterm neonates: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25872943" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Osteopathic manipulative treatment and pain in preterms: study protocol for a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27607517" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Does noninvasive electrical stimulation of acupuncture points reduce heelstick pain in neonates?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26242287" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Acupressure at BL60 and K3 Points Before Heel Lancing in Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26438556" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Laser acupuncture before heel lancing for pain management in healthy term newborns: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27420164" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Sucrose for analgesia in newborn infants undergoing painful procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27986905" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Sweet Solutions to Reduce Procedural Pain in Neonates: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23748256" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : A systematic review and meta-analyses of nonsucrose sweet solutions for pain relief in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7796057" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Pain-reducing properties of sucrose in human newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9925903" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Effect of repeated doses of sucrose during heel stick procedure in preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12205254" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26583940" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28157669" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Waiting 2 minutes after sucrose administration-unnecessary?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16215340" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Consistent management of repeated procedural pain with sucrose in preterm neonates: Is it effective and safe for repeated use over time?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31728675" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Repeating a dose of sucrose for heel prick procedure in preterms is not effective in reducing pain: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27474944" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Efficacy and safety of repeated oral sucrose for repeated procedural pain in neonates: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20403938" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Considerations for using sucrose to reduce procedural pain in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18591525" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15805377" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The role of endogenous opioids in mediating pain reduction by orally administered glucose among newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14609895" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Beta-endorphin concentration after administration of sucrose in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28160271" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Topical anaesthesia for needle-related pain in newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15662361" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : EMLA for painful procedures in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8523173" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Safety of lidocaine-prilocaine cream in the treatment of preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23129077" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Arrhythmia associated with tetracaine in an extremely low birth weight premature infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15777110" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : A critical review of the topical local anesthetic amethocaine (Ametop) for pediatric pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10566919" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Topical amethocaine (Ametop) is superior to EMLA for intravenous cannulation. Eutectic mixture of local anesthetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30587535" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Efficacy and Safety of EMLA Cream for Pain Control Due to Venipuncture in Infants: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21669894" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Analgesic effects of EMLA cream and oral sucrose during venipuncture in preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22743744" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Needle-free jet injection of lidocaine for local anesthesia during lumbar puncture: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8134222" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Acetaminophen analgesia in neonatal circumcision: the effect on pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10194994" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Randomised controlled trial of paracetamol for heel prick pain in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31985830" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Paracetamol (acetaminophen) for prevention or treatment of pain in newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28558384" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Randomized Controlled Trial Comparing Different Single Doses of Intravenous Paracetamol for Placement of Peripherally Inserted Central Catheters in Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28617422" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Reduced narcotic and sedative utilization in a NICU after implementation of pain management guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28720398" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Perinatal and neonatal use of paracetamol for pain relief.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170045" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10579478" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325815" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15787918" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11152028" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Treatment with paracetamol in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10930964" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21317433" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : The pharmacokinetics of intravenous paracetamol in neonates: size matters most.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24431352" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Intravenous paracetamol dosage in the neonate and small infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17284514" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Rectal acetaminophen does not reduce morphine consumption after major surgery in young infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23170854" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : The paracetamol concentration-effect relation in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22935063" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Paracetamol (acetaminophen) efficacy and safety in the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23299606" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26323200" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Intravenous Paracetamol Decreases Requirements of Morphine in Very Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29991471" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Clinically effective implementation of intravenous paracetamol as primary analgesia after major surgery in neonates and young infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33184168" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : A Quality Improvement Intervention to Reduce Postoperative Opiate Use in Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2656066" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Management of pain in the postoperative neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10484791" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Predicting concentrations in children presenting with acetaminophen overdose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21233080" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Does intravenous paracetamol administration affect body temperature in neonates?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32943529" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Intravenous paracetamol for neonates: long-term diseases not escalated during 5 years of follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9773385" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21683202" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Safety of ketorolac in surgical neonates and infants 0 to 3 months old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30509743" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25058748" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Standardizing morphine use for ventilated preterm neonates with a nursing-driven comfort protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24417623" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Is there an alternative to continuous opioid infusion for neonatal pain control? A preliminary report of parent/nurse-controlled analgesia in the neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31494028" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : A Pilot Randomized Controlled Trial of Outcomes Associated with Parent-Nurse Controlled Analgesia vs. Continuous Opioid Infusion in the Neonatal Intensive Care Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19731193" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Comparison of sufentanil versus fentanyl in ventilated term neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9931520" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: A randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23622445" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Comparison of fentanyl and morphine in laser surgery for retinopathy of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9740886" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20403936" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Tolerance and withdrawal from prolonged opioid use in critically ill children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15867047" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22561320" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Chest wall rigidity in two infants after low-dose fentanyl administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10201714" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11568372" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Midazolam sedation in mechanically ventilated newborns: a double blind randomized placebo controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7915348" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28141899" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21701267" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Midazolam activates the intrinsic pathway of apoptosis independent of benzodiazepine and death receptor signaling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559316" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Drugs of choice for sedation and analgesia in the neonatal ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7924769" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Doppler ultrasound assessment of the effects of ketamine on neonatal cerebral circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11420324" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Ketamine for procedural pain relief in newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36911029" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Combination of ketamine and fentanyl (KetaFent) for safe insertion of ultrasound-guided central venous catheters in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34531205" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : 'NOPAIN-ROP' trial: Intravenous fentanyl and intravenous ketamine for pain relief during laser photocoagulation for retinopathy of prematurity (ROP) in preterm infants: A randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37014033" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Non-opioid analgesics for procedural pain in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17572325" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12749653" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38025141" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : The Use of Dexmedetomidine in Preterm Infants: A Single Academic Center Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35119438" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37845426" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Efficacy and safety of dexmedetomidine for analgesia and sedation in neonates: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24238862" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37921767" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17485450" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23889264" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Clinical evaluation of propofol as sedative for endotracheal intubation in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32248549" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Propofol in neonates causes a dose-dependent profound and protracted decrease in blood pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20642659" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
